| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
AAZTA5-squaramide ester competing with DOTA-, DTPA- and CHX-A″-DTPA-analogues: Promising tool for 177Lu-labeling of monoclonal antibodies under mild conditions
|
Klasen, Benedikt
|
|
|
136-137 |
C |
p. 80-93
|
artikel
|
| 2 |
A brief history of the Society of Radiopharmaceutical Sciences
|
Coenen, Heinz H.
|
|
|
136-137 |
C |
p. 31-34
|
artikel
|
| 3 |
Accuracy of [68Ga]Ga-RM2-PET/CT for diagnosis of primary prostate cancer compared to histopathology
|
Fassbender, Thomas F.
|
|
2019
|
136-137 |
C |
p. 32-38
|
artikel
|
| 4 |
A comparative PET imaging study of 44gSc- and 68Ga-labeled bombesin antagonist BBN2 derivatives in breast and prostate cancer models
|
Ferguson, Simon
|
|
|
136-137 |
C |
p. 74-83
|
artikel
|
| 5 |
A comparative study of peptide-based imaging agents [68Ga]Ga-PSMA-11, [68Ga]Ga-AMBA, [68Ga]Ga-NODAGA-RGD and [68Ga]Ga-DOTA-NT-20.3 in preclinical prostate tumour models
|
Zhang-Yin, Jules
|
|
|
136-137 |
C |
p. 88-95
|
artikel
|
| 6 |
A comparison of DFO and DFO* conjugated to trastuzumab-DM1 for complexing 89Zr – In vitro stability and in vivo microPET/CT imaging studies in NOD/SCID mice with HER2-positive SK-OV-3 human ovarian cancer xenografts
|
Cho, Hyungjun
|
|
|
136-137 |
C |
p. 11-19
|
artikel
|
| 7 |
Actinium-225 photonuclear production in nuclear reactors using a mixed radium-226 and gadolinium-157 target
|
Matyskin, Artem V.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 8 |
Adaptation of a commercially available module for the production of alpha-[11C]methyl-L-tryptophan ([11C]AMT) for human use
|
Bamminger, Karsten
|
|
|
136-137 |
C |
p.
|
artikel
|
| 9 |
A decade of ubiquicidin development for PET imaging of infection: A systematic review
|
Marjanovic-Painter, Biljana
|
|
|
136-137 |
C |
p.
|
artikel
|
| 10 |
Advancements in the development of radiopharmaceuticals for nuclear medicine applications in the treatment of bone metastases
|
Dyer, Michael R.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 11 |
Affinity maturation and optimization of CD44v6-targeting antibodies for molecular radiotherapy
|
Mortensen, Anja Charlotte Lundgren
|
|
|
136-137 |
C |
p.
|
artikel
|
| 12 |
A kit formulation for the preparation of [89Zr]Zr(oxinate)4 for PET cell tracking: White blood cell labelling and comparison with [111In]In(oxinate)3
|
Man, Francis
|
|
|
136-137 |
C |
p. 31-40
|
artikel
|
| 13 |
Alanine and glycine conjugates of (2S,4R)-4-[18F]fluoroglutamine for tumor imaging
|
Zha, Zhihao
|
|
2018
|
136-137 |
C |
p. 19-28
|
artikel
|
| 14 |
Al[18F]F-complexation of DFH17, a NOTA-conjugated adrenomedullin analog, for PET imaging of pulmonary circulation
|
Alonso Martinez, Luis Michel
|
|
2018
|
136-137 |
C |
p. 36-42
|
artikel
|
| 15 |
Alkaline degradation of lyophilized DMSA prior to labeling with 99mTc: Identification and development of the degradation pathway by HPLC and MS
|
Almeida, Erika V.
|
|
2018
|
136-137 |
C |
p. 20-27
|
artikel
|
| 16 |
Alpha Atlas: Mapping global production of α-emitting radionuclides for targeted alpha therapy
|
Tosato, Marianna
|
|
|
136-137 |
C |
p.
|
artikel
|
| 17 |
Alpha emitting nuclides for targeted therapy
|
Hatcher-Lamarre, Jasmine L.
|
|
|
136-137 |
C |
p. 228-240
|
artikel
|
| 18 |
Amide-to-triazole switch vs. in vivo NEP-inhibition approaches to promote radiopeptide targeting of GRPR-positive tumors
|
Maina, Theodosia
|
|
2017
|
136-137 |
C |
p. 57-62
6 p.
|
artikel
|
| 19 |
A multi species evaluation of the radiation dosimetry of [11C]erlotinib, the radiolabeled analog of a clinically utilized tyrosine kinase inhibitor
|
Petrulli, J. Ryan
|
|
2017
|
136-137 |
C |
p. 56-61
|
artikel
|
| 20 |
An alternative radiochemical separation strategy for isolation of Ac and Ra isotopes from high energy proton irradiated thorium targets for further application in Targeted Alpha Therapy (TAT)
|
Baimukhanova, Ayagoz
|
|
|
136-137 |
C |
p. 35-43
|
artikel
|
| 21 |
An electrochemical approach for removal of radionuclidic contaminants of Eu from 153Sm for effective use in metastatic bone pain palliation
|
Chakravarty, Rubel
|
|
2018
|
136-137 |
C |
p. 8-19
|
artikel
|
| 22 |
An electrochemical generator for the continual supply of 213Bi from 225Ac for use in targeted alpha therapy applications
|
Forrester, Ryan
|
|
|
136-137 |
C |
p.
|
artikel
|
| 23 |
A new method measuring the interaction of radiotracers with the human P-glycoprotein (P-gp) transporter
|
Vraka, Chrysoula
|
|
2018
|
136-137 |
C |
p. 29-36
|
artikel
|
| 24 |
An improved automated one-pot synthesis of O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) based on a purification by cartridges
|
Bogni, A.
|
|
2019
|
136-137 |
C |
p. 11-19
|
artikel
|
| 25 |
An original radio-biomimetic approach to synthesize radiometabolites for PET imaging
|
Auvity, Sylvain
|
|
|
136-137 |
C |
p. 10-14
|
artikel
|
| 26 |
A novel anti-angiogenic radio/photo sensitizer for prostate cancer imaging and therapy: 89Zr-Pt@TiO2-SPHINX, synthesis and in vitro evaluation
|
Tekin, Volkan
|
|
|
136-137 |
C |
p. 20-31
|
artikel
|
| 27 |
A novel synergistic drug combination of a mitogen-activated extracellular signal-regulated kinase inhibitor with [177Lu]Lu-rhPSMA-10.1 for prostate cancer treatment: Results of a preclinical evaluation
|
Foxton, Caroline
|
|
|
136-137 |
C |
p.
|
artikel
|
| 28 |
Antimicrobial peptide LyeTx I mn∆K labeled with 68Ga is a potential PET radiopharmaceutical for molecular imaging of infections
|
Fuscaldi, Leonardo Lima
|
|
|
136-137 |
C |
p.
|
artikel
|
| 29 |
Application of copper (I) selective ligands for PET imaging of reactive oxygen species through metabolic trapping
|
Tada, Tetsuro
|
|
|
136-137 |
C |
p.
|
artikel
|
| 30 |
Application of [99mTc]Tc-GSA in the diagnosis of Staphylococcus aureus infections
|
Mizutani, Asuka
|
|
|
136-137 |
C |
p.
|
artikel
|
| 31 |
Applying radiobiology to clinical molecular radiotherapy
|
Murray, Iain
|
|
|
136-137 |
C |
p. 1-3
|
artikel
|
| 32 |
Approaches to improve metabolic stability of a statine-based GRP receptor antagonist
|
Popp, Ilinca
|
|
2017
|
136-137 |
C |
p. 22-29
8 p.
|
artikel
|
| 33 |
A preliminary biodistribution study of [99mTc]sodium pertechnetate prepared from an electron linear accelerator and activated carbon-based 99mTc generator
|
Jang, Jaewoong
|
|
|
136-137 |
C |
p. 1-9
|
artikel
|
| 34 |
A radioiodinated rucaparib analogue as an Auger electron emitter for cancer therapy
|
Destro, Gianluca
|
|
|
136-137 |
C |
p.
|
artikel
|
| 35 |
A radiopharmaceutical [89Zr]Zr-DFO-nimotuzumab for immunoPET with epidermal growth factor receptor expression in vivo
|
Tang, Yu
|
|
2019
|
136-137 |
C |
p. 23-31
|
artikel
|
| 36 |
A rapid bead-based radioligand binding assay for the determination of target-binding fraction and quality control of radiopharmaceuticals
|
Sharma, Sai Kiran
|
|
2019
|
136-137 |
C |
p. 32-38
|
artikel
|
| 37 |
A receptor-binding radiopharmaceutical for imaging of traumatic brain injury in a rodent model: [99mTc]Tc-tilmanocept
|
Chen, Wen
|
|
|
136-137 |
C |
p. 107-114
|
artikel
|
| 38 |
A reverse 230U/226Th radionuclide generator for targeted alpha therapy applications
|
Mastren, Tara
|
|
|
136-137 |
C |
p. 69-73
|
artikel
|
| 39 |
Aryl isocyanide derivative for one-pot synthesis of purification-free 99mTc-labeled hexavalent targeting probe
|
Mizuno, Yuki
|
|
|
136-137 |
C |
p. 30-36
|
artikel
|
| 40 |
A simple device to convert a small-animal PET scanner into a multi-sample tissue and injection syringe counter
|
Green, Michael V.
|
|
2017
|
136-137 |
C |
p. 9-13
5 p.
|
artikel
|
| 41 |
A six-year longitudinal PET study of (+)-[11C]DTBZ binding to the VMAT2 in monkey brain
|
Kilbourn, Michael R.
|
|
2017
|
136-137 |
C |
p. 34-37
|
artikel
|
| 42 |
Assessing the feasibility of intranasal radiotracer administration for in brain PET imaging
|
Singh, Nisha
|
|
2018
|
136-137 |
C |
p. 32-39
|
artikel
|
| 43 |
Assessment of drug transporters involved in the urinary secretion of [99mTc]dimercaptosuccinic acid
|
Kobayashi, Masato
|
|
|
136-137 |
C |
p. 92-97
|
artikel
|
| 44 |
Assessment of PSMA targeting ligands bearing novel chelates with application to theranostics: Stability and complexation kinetics of 68Ga3+, 111In3+, 177Lu3+ and 225Ac3+
|
Kelly, James M.
|
|
2017
|
136-137 |
C |
p. 38-46
|
artikel
|
| 45 |
Association between gastrin-releasing peptide receptor expression as assessed with [68Ga]Ga-RM2 PET/CT and histopathological tumor regression after neoadjuvant chemotherapy in primary breast cancer
|
Michalski, Kerstin
|
|
|
136-137 |
C |
p. 37-43
|
artikel
|
| 46 |
Astatine-211 labeled anti-HER2 5F7 single domain antibody fragment conjugates: radiolabeling and preliminary evaluation
|
Choi, Jaeyeon
|
|
2018
|
136-137 |
C |
p. 10-20
|
artikel
|
| 47 |
Astatine-211-labeled aza-vesamicol derivatives as sigma receptor ligands for targeted alpha therapy
|
Ogawa, Kazuma
|
|
|
136-137 |
C |
p.
|
artikel
|
| 48 |
A third generation PSMA-targeted agent [211At]YF2: Synthesis and in vivo evaluation
|
Feng, Yutian
|
|
|
136-137 |
C |
p.
|
artikel
|
| 49 |
211At labeled substance P (5–11) as potential radiopharmaceutical for glioma treatment
|
Lyczko, Monika
|
|
2017
|
136-137 |
C |
p. 1-8
8 p.
|
artikel
|
| 50 |
A trithiol bifunctional chelate for 72,77As: A matched pair theranostic complex with high in vivo stability
|
Feng, Yutian
|
|
2018
|
136-137 |
C |
p. 1-10
|
artikel
|
| 51 |
Auger electron therapy of glioblastoma using [125I]5-iodo-2′-deoxyuridine and concomitant chemotherapy – Evaluation of a potential treatment strategy
|
Madsen, Karina Lindbøg
|
|
|
136-137 |
C |
p. 35-40
|
artikel
|
| 52 |
Auger: The future of precision medicine
|
Pirovano, Giacomo
|
|
|
136-137 |
C |
p. 50-53
|
artikel
|
| 53 |
A useful PET probe [11C]BU99008 with ultra-high specific radioactivity for small animal PET imaging of I2-imidazoline receptors in the hypothalamus
|
Kawamura, Kazunori
|
|
2017
|
136-137 |
C |
p. 1-7
7 p.
|
artikel
|
| 54 |
Automated production of [11C]butyrate for keto body PET imaging
|
Pakula, Ryan J.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 55 |
Automated production of [18F]SiTATE on a Scintomics GRP™ platform for PET/CT imaging of neuroendocrine tumors
|
Lindner, Simon
|
|
|
136-137 |
C |
p. 86-95
|
artikel
|
| 56 |
Automated radiosynthesis and preclinical evaluation of Al[18F]F-NOTA-P-GnRH for PET imaging of GnRH receptor-positive tumors
|
Huang, Shun
|
|
|
136-137 |
C |
p. 64-71
|
artikel
|
| 57 |
Automated radiosynthesis and preclinical in vivo evaluation of [18F]Fluoroethylpuromycin as a potential radiotracer for imaging protein synthesis with PET
|
Ramakrishnan, Nisha K.
|
|
|
136-137 |
C |
p. 71-77
|
artikel
|
| 58 |
Automated radiosynthesis of 5-[11C]l-glutamine, an important tracer for glutamine utilization
|
Rosenberg, Adam J.
|
|
2018
|
136-137 |
C |
p. 10-14
|
artikel
|
| 59 |
Automated radiosynthesis of [89Zr]Zr-DFOSq-Durvalumab for imaging of PD-L1 expressing tumours in vivo
|
Wichmann, Christian W.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 60 |
Automated two-step manufacturing of [11C]glyburide radiopharmaceutical for PET imaging in humans
|
Caillé, Fabien
|
|
|
136-137 |
C |
p. 20-27
|
artikel
|
| 61 |
Automation of simplified two-step radiolabeling via ditosylate synthon for 18F-labeled radiotracers using AllinOne module
|
Li, Shihong
|
|
|
136-137 |
C |
p.
|
artikel
|
| 62 |
Baseline and longitudinal variability of normal tissue uptake values of [18F]-fluorothymidine-PET images
|
Cysouw, Matthijs C.F.
|
|
2017
|
136-137 |
C |
p. 18-24
7 p.
|
artikel
|
| 63 |
B7-H3-targeted 212Pb radioimmunotherapy of ovarian cancer in preclinical models
|
Kasten, Benjamin B.
|
|
2017
|
136-137 |
C |
p. 23-30
|
artikel
|
| 64 |
Biodistribution and long-term toxicity of neutron-activated Samarium-153 oxide-loaded polystyrene microspheres in healthy rats
|
Tan, Hun Yee
|
|
|
136-137 |
C |
p.
|
artikel
|
| 65 |
Biodistribution and radiation dosimetry of D-isomer of 4-borono-2-[18F]fluoro-phenylalanine: A comparative PET/CT study with L-isomer in healthy human volunteers
|
Yang, Qiao
|
|
|
136-137 |
C |
p. 32-37
|
artikel
|
| 66 |
Biodistribution, dosimetry, and temporal signal-to-noise ratio analyses of normal and cancer uptake of [68Ga]Ga-P15-041, a gallium-68 labeled bisphosphonate, from first-in-human studies
|
Doot, Robert K.
|
|
|
136-137 |
C |
p. 1-8
|
artikel
|
| 67 |
Biodistribution of [18F]BCPP-BF in humans: a first-in-human positron emission tomography study
|
Sato, Kengo
|
|
|
136-137 |
C |
p.
|
artikel
|
| 68 |
Biodistribution study of 211Pb progeny released from intravenously applied 223Ra labelled TiO2 nanoparticles in a mouse model
|
Sakmár, Michal
|
|
|
136-137 |
C |
p.
|
artikel
|
| 69 |
Biokinetics, radiopharmacokinetics and estimation of the absorbed dose in healthy organs due to Technetium-99m transported in the core and on the surface of reconstituted high-density lipoprotein nanoparticles
|
Pérez-Velasco, Diana L.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 70 |
Biological evaluation of a novel stable peptide PET molecular probe [18F]AlF-NOTA-DVAP targeting to tumor cell surface GRP78
|
Yao, Bolin
|
|
|
136-137 |
C |
p.
|
artikel
|
| 71 |
Biologicals as theranostic vehicles in paediatric oncology
|
Niessen, Veerle J.A.
|
|
|
136-137 |
C |
p. 58-64
|
artikel
|
| 72 |
Bismuth chelation for targeted alpha therapy: Current state of the art
|
Franchi, Sara
|
|
|
136-137 |
C |
p. 168-188
|
artikel
|
| 73 |
Blood and urine analyses after radioembolization of liver malignancies with [166Ho]Ho-acetylacetonate-poly(l-lactic acid) microspheres
|
Bakker, Robbert C.
|
|
2019
|
136-137 |
C |
p. 11-18
|
artikel
|
| 74 |
BLZ945 derivatives for PET imaging of colony stimulating factor-1 receptors in the brain
|
van der Wildt, Berend
|
|
|
136-137 |
C |
p. 44-51
|
artikel
|
| 75 |
Brain drug delivery from the nasal olfactory region is enhanced using lauroylcholine chloride: An estimation using in vivo PET imaging
|
Fukakusa, Shota
|
|
|
136-137 |
C |
p.
|
artikel
|
| 76 |
Brain pharmacokinetics and biodistribution of 11C-labeled isoproterenol in rodents
|
Ogata, Aya
|
|
|
136-137 |
C |
p. 52-58
|
artikel
|
| 77 |
Brain uptake and metabolism of the endocannabinoid anandamide labeled in either the arachidonoyl or ethanolamine moiety
|
Hu, Kun
|
|
2017
|
136-137 |
C |
p. 43-50
8 p.
|
artikel
|
| 78 |
Brown adipose tissue imaging using the TSPO tracer [18F]fluoromethyl-PBR28-d
2: A comparison with [18F]FDG
|
Oh, Chiwoo
|
|
|
136-137 |
C |
p. 98-103
|
artikel
|
| 79 |
Brush border enzyme-cleavable linkers: Evaluation for reducing renal uptake of radiolabeled prostate-specific membrane antigen inhibitors
|
Vaidyanathan, Ganesan
|
|
|
136-137 |
C |
p. 18-30
|
artikel
|
| 80 |
Bulk production and evaluation of high specific activity 186gRe for cancer therapy using enriched 186WO3 targets in a proton beam
|
Mastren, Tara
|
|
2017
|
136-137 |
C |
p. 24-29
|
artikel
|
| 81 |
Cannabinoid receptor type 2 (CB2) as one of the candidate genes in human carotid plaque imaging: Evaluation of the novel radiotracer [11C]RS-016 targeting CB2 in atherosclerosis
|
Meletta, Romana
|
|
2017
|
136-137 |
C |
p. 31-43
|
artikel
|
| 82 |
Carbon-11-labelling of the histone deacetylase 6 radioligand EKZ-001
|
Tago, Tetsuro
|
|
|
136-137 |
C |
p.
|
artikel
|
| 83 |
[11C]AZ10419096 – a full antagonist PET radioligand for imaging brain 5-HT1B receptors
|
Lindberg, Anton
|
|
2017
|
136-137 |
C |
p. 34-40
7 p.
|
artikel
|
| 84 |
Cell death PET/CT imaging of rat hepatic fibrosis with 18F-labeled small molecule tracer
|
Su, Shu
|
|
|
136-137 |
C |
p. 76-83
|
artikel
|
| 85 |
Cerebral and myocardial kinetics of [11C]acetoacetate and [11C]β-hydroxybutyrate: A comparative crossover study in healthy rats
|
Kjærulff, Mette Louise Gram
|
|
|
136-137 |
C |
p.
|
artikel
|
| 86 |
[11C]Erlotinib PET cannot detect acquired erlotinib resistance in NSCLC tumor xenografts in mice
|
Traxl, Alexander
|
|
2017
|
136-137 |
C |
p. 7-15
9 p.
|
artikel
|
| 87 |
Characterization of actinide resin for separation of 51,52gMn from bulk target material
|
Barrett, Kendall E.
|
|
|
136-137 |
C |
p. 19-26
|
artikel
|
| 88 |
Characterization of a novel PET radioligand for mitochondrial complex I in nonhuman primate
|
Xu, Yulong
|
|
|
136-137 |
C |
p.
|
artikel
|
| 89 |
Characterization of a S1PR2 specific 11C-labeled radiotracer in streptozotocin-induced diabetic murine model
|
Jiang, Hao
|
|
|
136-137 |
C |
p.
|
artikel
|
| 90 |
Chelation chemistry of manganese-52 for PET imaging applications
|
Omweri, James M.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 91 |
Chemokine receptor PET imaging: Bridging molecular insights with clinical applications
|
Hunter, Chanelle
|
|
|
136-137 |
C |
p.
|
artikel
|
| 92 |
Clinical evaluation of [68Ga]Ga-DATA-TOC in comparison to [68Ga]Ga-DOTA-TOC in patients with neuroendocrine tumours
|
Gaertner, F.C.
|
|
|
136-137 |
C |
p. 1-9
|
artikel
|
| 93 |
Clinical 68Ga-PET: Is radiosynthesis module an absolute necessity?
|
Chakravarty, Rubel
|
|
2017
|
136-137 |
C |
p. 1-11
11 p.
|
artikel
|
| 94 |
Clinical results and economic considerations of 68Ga-PSMA and radiolabeled choline in prostate cancer
|
Evangelista, Laura
|
|
2017
|
136-137 |
C |
p. 47-49
|
artikel
|
| 95 |
Clinical scale synthesis of intrinsically radiolabeled and cyclic RGD peptide functionalized 198Au nanoparticles for targeted cancer therapy
|
Chakravarty, Rubel
|
|
2019
|
136-137 |
C |
p. 1-10
|
artikel
|
| 96 |
Clinical translation of a PSMA inhibitor for 99mTc-based SPECT
|
Ferro-Flores, Guillermina
|
|
2017
|
136-137 |
C |
p. 36-44
9 p.
|
artikel
|
| 97 |
Clinical usefulness of 18F–FDG PET/CT for initial staging and assessment of treatment efficacy in patients with lymph node tuberculosis
|
Lefebvre, Nicolas
|
|
2017
|
136-137 |
C |
p. 17-24
|
artikel
|
| 98 |
Combination radionuclide therapy: A new paradigm
|
Suman, Shishu Kant
|
|
|
136-137 |
C |
p. 40-58
|
artikel
|
| 99 |
Combining poly-epitope MoonTags and labeled nanobodies for signal amplification in cell-specific PET imaging in vivo
|
Höffgen, Katharina S.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 100 |
Commentary
|
Eckelman, William C.
|
|
2017
|
136-137 |
C |
p. 1-3
3 p.
|
artikel
|
| 101 |
Comparative evaluation of [18F]DiFA and its analogs as novel hypoxia positron emission tomography and [18F]FMISO as the standard
|
Nakata, Norihito
|
|
2019
|
136-137 |
C |
p. 39-45
|
artikel
|
| 102 |
Comparative evaluation of radiolabeled bombesin analogs [177Lu]Lu-AMBA and [177Lu]Lu-RM2 for targeting GRPR in glioblastoma model
|
Grzmil, Michal
|
|
|
136-137 |
C |
p.
|
artikel
|
| 103 |
Comparison between [18F]fluorination and [18F]fluoroethylation reactions for the synthesis of the PDE10A PET radiotracer [18F]MNI-659
|
Mori, Wakana
|
|
2017
|
136-137 |
C |
p. 12-18
|
artikel
|
| 104 |
Comparison of analytical methods for antibody conjugates with application in nuclear imaging – Report from the trenches
|
Feiner, Irene V.J.
|
|
|
136-137 |
C |
p. 24-33
|
artikel
|
| 105 |
Comparison of 68Ga-labeled RGD mono- and multimers based on a clickable siderophore-based scaffold
|
Kaeopookum, Piriya
|
|
|
136-137 |
C |
p. 1-10
|
artikel
|
| 106 |
Comparison of planar, PET and well-counter measurements of total tumor radioactivity in a mouse xenograft model
|
Green, Michael V.
|
|
2017
|
136-137 |
C |
p. 29-36
8 p.
|
artikel
|
| 107 |
Comparison of the synthesis and biological properties of no-carrier-added and carrier-added 4-borono-2-[18F]fluorophenylalanine ([18F]FBPA)
|
Chang, Ting-Yu
|
|
|
136-137 |
C |
p.
|
artikel
|
| 108 |
Comparison of various radioactive payloads for a human monoclonal antibody to glycoprotein 41 for elimination of HIV-infected cells
|
Garg, Ravendra
|
|
|
136-137 |
C |
p. 80-88
|
artikel
|
| 109 |
Concepts for design and analysis of receptor radiopharmaceuticals: The Receptor-Binding Radiotracers series of meetings provided the foundation
|
Krohn, Kenneth A.
|
|
|
136-137 |
C |
p. 5-23
|
artikel
|
| 110 |
Consensus nomenclature rules for radiopharmaceutical chemistry — Setting the record straight
|
Coenen, Heinz H.
|
|
2017
|
136-137 |
C |
p. v-xi
|
artikel
|
| 111 |
Contents
|
|
|
|
136-137 |
C |
p. OBC
|
artikel
|
| 112 |
Continuation of comprehensive quality control of the itG 68Ge/68Ga generator and production of 68Ga-DOTATOC and 68Ga-PSMA-HBED-CC for clinical research studies
|
Amor-Coarasa, Alejandro
|
|
2017
|
136-137 |
C |
p. 37-39
3 p.
|
artikel
|
| 113 |
Contribution of neuroinflammation to changes in [11C]flumazenil binding in the rat brain: Evaluation of the inflamed pons as reference tissue
|
Parente, Andrea
|
|
2017
|
136-137 |
C |
p. 50-56
|
artikel
|
| 114 |
Co-production of 155Tb and 152Tb irradiating 155Gd / 151Eu tandem target with a medium energy α-particle beam
|
Moiseeva, A.N.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 115 |
Correlation of hypoxia PET tracer uptake with hypoxic radioresistance in cancer cells: PET biomarkers of resistance to stereotactic radiation therapy?
|
Chia, Kazumi
|
|
|
136-137 |
C |
p. 10-17
|
artikel
|
| 116 |
Corrigendum to “Alpha Atlas: Mapping global production of α-emitting radionuclides for targeted alpha therapy” [Nucl Med Biol (March–April 2025) 108990]
|
Tosato, Marianna
|
|
|
136-137 |
C |
p.
|
artikel
|
| 117 |
Corrigendum to “131I-labeled chitosan hydrogels for radioembolization: a preclinical study in small animals” [Nucl Med Biol 52 (2017) 16–23]
|
Hwang, Hyosook
|
|
2018
|
136-137 |
C |
p. 50
|
artikel
|
| 118 |
Corrigendum to ‘212Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models’ [Nucl Med Biol 58 (2018) 67–73]
|
Kasten, Benjamin B.
|
|
2018
|
136-137 |
C |
p. 71
|
artikel
|
| 119 |
Corrigendum to “radiation dosimetry of the 18 kDa translocator protein ligand [18F]PBR111 in humans” [nuclear medicine and biology, 144–145 (2025); 109,011]
|
Tournier, Benjamin B.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 120 |
Corrigendum to “SSP-27: 89Zr-immuno-PET of a novel bispecific amyloid β monoclonal antibody reveals improved and high specific brain uptake” [Nucl Med Biol (2020) Volumes 96–97, Supplement. S30-S31]
|
Stergiou, N.
|
|
|
136-137 |
C |
p. 65
|
artikel
|
| 121 |
[11C]PF-3274167 as a PET radiotracer of oxytocin receptors: Radiosynthesis and evaluation in rat brain
|
Vidal, Benjamin
|
|
2017
|
136-137 |
C |
p. 1-6
|
artikel
|
| 122 |
[11C]phosgene: Synthesis and application for development of PET radiotracers
|
Fukumura, Toshimitsu
|
|
|
136-137 |
C |
p. 138-148
|
artikel
|
| 123 |
Cross-sectional and longitudinal small animal PET shows pre and post-synaptic striatal dopaminergic deficits in an animal model of HIV
|
Sinharay, Sanhita
|
|
2017
|
136-137 |
C |
p. 27-33
|
artikel
|
| 124 |
Cross sections of the 226Ra(p,xn) reactions relevant for 225Ac production
|
Lebeda, Ondřej
|
|
|
136-137 |
C |
p.
|
artikel
|
| 125 |
64Cu production via the 68Zn(p,nα)64Cu nuclear reaction: An untapped, cost-effective and high energy production route
|
Nelson, Bryce J.B.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 126 |
Current trends in the use of O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) in neurooncology
|
Stegmayr, Carina
|
|
|
136-137 |
C |
p. 78-84
|
artikel
|
| 127 |
Cyclotron production of 68Ga in a liquid target: Effects of solution composition and irradiation parameters
|
Pandey, Mukesh K.
|
|
|
136-137 |
C |
p. 49-55
|
artikel
|
| 128 |
Cyclotron production of 99mTc
|
Gumiela, Magdalena
|
|
2018
|
136-137 |
C |
p. 33-41
|
artikel
|
| 129 |
Cyclotron production of 103Pd using a liquid target
|
Krol, Viktoria
|
|
|
136-137 |
C |
p.
|
artikel
|
| 130 |
Decreased striatal vesicular monoamine transporter 2 (VMAT2) expression in a type 1 diabetic rat model: A longitudinal study using micro-PET/CT
|
Jiang, Donglang
|
|
|
136-137 |
C |
p. 89-95
|
artikel
|
| 131 |
Delivery systems exploiting natural cell transport processes of macromolecules for intracellular targeting of Auger electron emitters
|
Rosenkranz, Andrey A.
|
|
|
136-137 |
C |
p. 45-56
|
artikel
|
| 132 |
Demystifying solid targets: Simple and rapid distribution-scale production of [68Ga]GaCl3 and [68Ga]Ga-PSMA-11
|
Svedjehed, Johan
|
|
|
136-137 |
C |
p. 1-10
|
artikel
|
| 133 |
Design and preclinical evaluation of nanostars for the passive pretargeting of tumor tissue
|
Goos, Jeroen A.C.M.
|
|
|
136-137 |
C |
p. 63-72
|
artikel
|
| 134 |
Design, synthesis and evaluation of 111In labeled DOTA-conjugated tetrapeptides having high affinity and selectivity for mu opioid receptors
|
Lever, John R.
|
|
2019
|
136-137 |
C |
p. 53-66
|
artikel
|
| 135 |
Detection of melanoma metastases with PET—Comparison of 18F-5-FPN with 18F–FDG
|
Wang, Yichun
|
|
2017
|
136-137 |
C |
p. 33-38
|
artikel
|
| 136 |
Deuterated [18F]fluoroethyl tropane analogs as dopamine transporter probes: Synthesis and biological evaluation
|
Li, Qingming
|
|
|
136-137 |
C |
p.
|
artikel
|
| 137 |
Deuterated 18F-9-O-hexadeutero-3-fluoropropoxyl-(+)-dihydrotetrabenazine (D6-FP-(+)-DTBZ): A vesicular monoamine transporter 2 (VMAT2) imaging agent
|
Liu, Futao
|
|
2018
|
136-137 |
C |
p. 42-49
|
artikel
|
| 138 |
Developing new PET tracers to image the growth hormone secretagogue receptor 1a (GHS-R1a)
|
Kawamura, Kazunori
|
|
2017
|
136-137 |
C |
p. 49-56
8 p.
|
artikel
|
| 139 |
Development and biodistribution studies of 77As-labeled trithiol RM2 bioconjugates for prostate cancer: Comparison of [77As]As-trithiol-Ser-Ser-RM2 vs. [77As]As-trithiol-Glu-Ser-RM2
|
Ma, Li
|
|
|
136-137 |
C |
p. 61-69
|
artikel
|
| 140 |
Development and in vitro evaluation of new bifunctional 89Zr-chelators based on the 6-amino-1,4-diazepane scaffold for immuno-PET applications
|
Klasen, Benedikt
|
|
|
136-137 |
C |
p. 12-23
|
artikel
|
| 141 |
Development and validation of the HPLC method for quality control of radiolabelled DOTA-TATE and DOTA-TOC preparations
|
Radzik, Marcin
|
|
|
136-137 |
C |
p. 63-73
|
artikel
|
| 142 |
Development of 225Ac/213Bi generator based on α-ZrP-PAN composite for targeted alpha therapy
|
Ondrák, Lukáš
|
|
|
136-137 |
C |
p.
|
artikel
|
| 143 |
Development of a CCR2 targeted 18F-labeled radiotracer for atherosclerosis imaging with PET
|
Zhang, Xiaohui
|
|
|
136-137 |
C |
p.
|
artikel
|
| 144 |
Development of a 18F-labeled PET radioligand for imaging 5-HT1B receptors: [18F]AZ10419096
|
Lindberg, Anton
|
|
|
136-137 |
C |
p. 11-16
|
artikel
|
| 145 |
Development of a novel radiobromine-labeled sigma-1 receptor imaging probe
|
Ogawa, Kazuma
|
|
2018
|
136-137 |
C |
p. 28-35
|
artikel
|
| 146 |
Development of a PET radioligand selective for cerebral amyloid angiopathy
|
Abrahamson, Eric E.
|
|
|
136-137 |
C |
p. 85-96
|
artikel
|
| 147 |
Development of a preclinical 211Rn/211At generator system for targeted alpha therapy research with 211At
|
Crawford, Jason R.
|
|
2017
|
136-137 |
C |
p. 31-35
5 p.
|
artikel
|
| 148 |
Development of a thin layer chromatography method for plasma correction of [18F]fluorocholine metabolites in positron emission tomography quantification studies in humans
|
Villar, Marina
|
|
|
136-137 |
C |
p. 34-40
|
artikel
|
| 149 |
Development of [11C]/[3H]THK-5351 – A potential novel carbon-11 tau imaging PET radioligand
|
Stepanov, Vladimir
|
|
2017
|
136-137 |
C |
p. 50-53
4 p.
|
artikel
|
| 150 |
Development of [18F]FAMTO: A novel fluorine-18 labelled positron emission tomography (PET) radiotracer for imaging CYP11B1 and CYP11B2 enzymes in adrenal glands
|
Bongarzone, Salvatore
|
|
2019
|
136-137 |
C |
p. 14-21
|
artikel
|
| 151 |
Development of fluorine-18 labeled peptidic PET tracers for imaging active tissue transglutaminase
|
van der Wildt, Berend
|
|
2017
|
136-137 |
C |
p. 90-104
15 p.
|
artikel
|
| 152 |
Development of novel 67/68Ga-labeled pyridyl benzofuran derivatives as islet amyloid imaging probes
|
Saito, Kosuke
|
|
|
136-137 |
C |
p. 72-79
|
artikel
|
| 153 |
Development of radioiodine labeled acetaminophen for specific, high-contrast imaging of malignant melanoma
|
Zhu, Wen Jing
|
|
2018
|
136-137 |
C |
p. 16-21
|
artikel
|
| 154 |
Development of technetium-99m labeled ultrafine gold nanobioconjugates for targeted imaging of folate receptor positive cancers
|
Kumar, Dheeraj
|
|
|
136-137 |
C |
p. 1-10
|
artikel
|
| 155 |
Development of two fluorine-18 labeled PET radioligands targeting PDE10A and in vivo PET evaluation in nonhuman primates
|
Stepanov, Vladimir
|
|
2018
|
136-137 |
C |
p. 12-19
|
artikel
|
| 156 |
(1→3)-β-D-glucan aptamers labeled with technetium-99m: Biodistribution and imaging in experimental models of bacterial and fungal infection
|
de Sousa Lacerda, Camila Maria
|
|
2017
|
136-137 |
C |
p. 19-24
6 p.
|
artikel
|
| 157 |
Differences in accumulation and the transport mechanism of l- and d-methionine in high- and low-grade human glioma cells
|
Kobayashi, Masato
|
|
2017
|
136-137 |
C |
p. 78-82
5 p.
|
artikel
|
| 158 |
Direct comparison of [18F]AlF-NOTA-JR11 and [18F]AlF-NOTA-octreotide for PET imaging of neuroendocrine tumors: Antagonist versus agonist
|
Ahenkorah, Stephen
|
|
|
136-137 |
C |
p.
|
artikel
|
| 159 |
Direct labeling of a somatostatin receptor antagonist via peptide cyclization with Re, 99mTc and 186Re metal centers: Radiochemistry and in vitro evaluation
|
Wang, Jing
|
|
|
136-137 |
C |
p. 46-52
|
artikel
|
| 160 |
Discovery of a CSF-1R inhibitor and PET tracer for imaging of microglia and macrophages in the brain
|
van der Wildt, Berend
|
|
|
136-137 |
C |
p. 99-107
|
artikel
|
| 161 |
Discovery, synthesis and evaluation of novel reversible monoacylglycerol lipase radioligands bearing a morpholine-3-one scaffold
|
He, Yingfang
|
|
|
136-137 |
C |
p. 24-32
|
artikel
|
| 162 |
Dose estimation after a mixed field exposure: Radium-223 and intensity modulated radiotherapy
|
Bastiani, Isabella
|
|
|
136-137 |
C |
p. 10-20
|
artikel
|
| 163 |
Dose-on-demand production of diverse 18F-radiotracers for preclinical applications using a continuous flow microfluidic system
|
Matesic, Lidia
|
|
2017
|
136-137 |
C |
p. 24-31
8 p.
|
artikel
|
| 164 |
DOTA-tetrazine probes with modified linkers for tumor pretargeting
|
Läppchen, Tilman
|
|
2017
|
136-137 |
C |
p. 19-26
|
artikel
|
| 165 |
Do we say what we mean and mean what we say?
|
Coenen, Heinz H.
|
|
2017
|
136-137 |
C |
p. 53-54
2 p.
|
artikel
|
| 166 |
Drug and molecular radiotherapy combinations for metastatic castration resistant prostate cancer
|
Staniszewska, Magdalena
|
|
|
136-137 |
C |
p. 101-111
|
artikel
|
| 167 |
Dual-isotope imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours
|
Knight, James C.
|
|
2019
|
136-137 |
C |
p. 14-22
|
artikel
|
| 168 |
Dynamic TSPO-PET for assessing early effects of cerebral hypoxia and resuscitation in new born pigs
|
de Lange, Charlotte
|
|
2018
|
136-137 |
C |
p. 49-57
|
artikel
|
| 169 |
Editorial Board
|
|
|
2017
|
136-137 |
C |
p. IFC-
1 p.
|
artikel
|
| 170 |
Editorial Board
|
|
|
2017
|
136-137 |
C |
p. IFC-
1 p.
|
artikel
|
| 171 |
Editorial Board
|
|
|
2017
|
136-137 |
C |
p. IFC-
1 p.
|
artikel
|
| 172 |
Editorial Board
|
|
|
2017
|
136-137 |
C |
p. IFC-
1 p.
|
artikel
|
| 173 |
Editorial Board
|
|
|
|
136-137 |
C |
p. ii
|
artikel
|
| 174 |
Editorial Board
|
|
|
|
136-137 |
C |
p. ii
|
artikel
|
| 175 |
Editorial Board
|
|
|
|
136-137 |
C |
p. ii
|
artikel
|
| 176 |
Editorial Board
|
|
|
2017
|
136-137 |
C |
p. IFC-
1 p.
|
artikel
|
| 177 |
Editorial Board
|
|
|
2017
|
136-137 |
C |
p. IFC-
1 p.
|
artikel
|
| 178 |
Editorial Board
|
|
|
2018
|
136-137 |
C |
p. IFC
|
artikel
|
| 179 |
Editorial Board
|
|
|
2018
|
136-137 |
C |
p. IFC
|
artikel
|
| 180 |
Editorial Board
|
|
|
2018
|
136-137 |
C |
p. IFC
|
artikel
|
| 181 |
Editorial Board
|
|
|
|
136-137 |
C |
p. IFC
|
artikel
|
| 182 |
Editorial Board
|
|
|
|
136-137 |
C |
p. IFC
|
artikel
|
| 183 |
Editorial Board
|
|
|
2017
|
136-137 |
C |
p. IFC
|
artikel
|
| 184 |
Editorial Board
|
|
|
2017
|
136-137 |
C |
p. IFC
|
artikel
|
| 185 |
Editorial Board
|
|
|
2017
|
136-137 |
C |
p. IFC
|
artikel
|
| 186 |
Editorial Board
|
|
|
2018
|
136-137 |
C |
p. IFC
|
artikel
|
| 187 |
Editorial Board
|
|
|
2017
|
136-137 |
C |
p. IFC-
1 p.
|
artikel
|
| 188 |
Editorial Board
|
|
|
2017
|
136-137 |
C |
p. IFC-
1 p.
|
artikel
|
| 189 |
Editorial Board
|
|
|
2017
|
136-137 |
C |
p. IFC
|
artikel
|
| 190 |
Editorial Board
|
|
|
2018
|
136-137 |
C |
p. IFC
|
artikel
|
| 191 |
Editorial Board
|
|
|
2018
|
136-137 |
C |
p. IFC
|
artikel
|
| 192 |
Editorial Board
|
|
|
2019
|
136-137 |
C |
p. ii
|
artikel
|
| 193 |
Editorial Board
|
|
|
2018
|
136-137 |
C |
p. IFC
|
artikel
|
| 194 |
Editorial Board
|
|
|
2018
|
136-137 |
C |
p. IFC
|
artikel
|
| 195 |
Editorial Board
|
|
|
2019
|
136-137 |
C |
p. ii
|
artikel
|
| 196 |
Editorial Board
|
|
|
2019
|
136-137 |
C |
p. ii
|
artikel
|
| 197 |
Editorial Board
|
|
|
2019
|
136-137 |
C |
p. ii
|
artikel
|
| 198 |
Editorial Board
|
|
|
|
136-137 |
C |
p. ii
|
artikel
|
| 199 |
Editorial Board
|
|
|
|
136-137 |
C |
p. ii
|
artikel
|
| 200 |
Editorial Board
|
|
|
|
136-137 |
C |
p. ii
|
artikel
|
| 201 |
Editorial Board
|
|
|
|
136-137 |
C |
p. ii
|
artikel
|
| 202 |
Editorial Board
|
|
|
|
136-137 |
C |
p. ii
|
artikel
|
| 203 |
Editorial Board
|
|
|
|
136-137 |
C |
p. ii
|
artikel
|
| 204 |
Editorial Board
|
|
|
|
136-137 |
C |
p. ii
|
artikel
|
| 205 |
Editorial Board
|
|
|
|
136-137 |
C |
p. ii
|
artikel
|
| 206 |
Editorial Board
|
|
|
|
136-137 |
C |
p. ii
|
artikel
|
| 207 |
Editorial Board
|
|
|
|
136-137 |
C |
p. ii
|
artikel
|
| 208 |
Editorial Board
|
|
|
|
136-137 |
C |
p. ii
|
artikel
|
| 209 |
Editorial Board
|
|
|
|
136-137 |
C |
p. ii
|
artikel
|
| 210 |
Editorial Board
|
|
|
|
136-137 |
C |
p. ii
|
artikel
|
| 211 |
Editorial Board
|
|
|
|
136-137 |
C |
p. ii
|
artikel
|
| 212 |
Editorial Board
|
|
|
|
136-137 |
C |
p. ii
|
artikel
|
| 213 |
Editorial Board
|
|
|
|
136-137 |
C |
p. ii
|
artikel
|
| 214 |
Editorial Board
|
|
|
|
136-137 |
C |
p. ii
|
artikel
|
| 215 |
Editorial Board
|
|
|
|
136-137 |
C |
p.
|
artikel
|
| 216 |
Editorial Board
|
|
|
|
136-137 |
C |
p.
|
artikel
|
| 217 |
Editorial Board
|
|
|
|
136-137 |
C |
p.
|
artikel
|
| 218 |
Editorial Board
|
|
|
|
136-137 |
C |
p. ii
|
artikel
|
| 219 |
Editorial Board
|
|
|
|
136-137 |
C |
p.
|
artikel
|
| 220 |
Editorial Board
|
|
|
|
136-137 |
C |
p. ii
|
artikel
|
| 221 |
Editorial Board
|
|
|
|
136-137 |
C |
p.
|
artikel
|
| 222 |
Editorial Board
|
|
|
|
136-137 |
C |
p.
|
artikel
|
| 223 |
Editorial Board
|
|
|
|
136-137 |
C |
p.
|
artikel
|
| 224 |
Editorial Board
|
|
|
|
136-137 |
C |
p.
|
artikel
|
| 225 |
Editorial Board
|
|
|
|
136-137 |
C |
p.
|
artikel
|
| 226 |
Editorial Board
|
|
|
|
136-137 |
C |
p.
|
artikel
|
| 227 |
Editorial Board
|
|
|
|
136-137 |
C |
p.
|
artikel
|
| 228 |
Editorial Board
|
|
|
|
136-137 |
C |
p.
|
artikel
|
| 229 |
Editorial Board
|
|
|
|
136-137 |
C |
p.
|
artikel
|
| 230 |
Editorial Board
|
|
|
|
136-137 |
C |
p.
|
artikel
|
| 231 |
Effectiveness and normal tissue toxicity of Auger electron (AE) radioimmunotherapy (RIT) with [111In]In-Bn-DTPA-nimotuzumab in mice with triple-negative or trastuzumab-resistant human breast cancer xenografts that overexpress EGFR
|
Chan, Conrad
|
|
|
136-137 |
C |
p. 37-44
|
artikel
|
| 232 |
Effect of methoxy group position on biological properties of 18F–labeled benzyl triphenylphosphonium cations
|
Chen, Shuting
|
|
2017
|
136-137 |
C |
p. 16-23
|
artikel
|
| 233 |
Effects of adding an albumin binder chain on [177Lu]Lu-DOTATATE
|
Rousseau, Etienne
|
|
2018
|
136-137 |
C |
p. 10-17
|
artikel
|
| 234 |
Effects of 18F-fluorinated neopentyl glycol side-chain on the biological characteristics of stilbene amyloid-β PET ligands
|
Tago, Tetsuro
|
|
|
136-137 |
C |
p. 38-45
|
artikel
|
| 235 |
Efficient cartridge purification for producing high molar activity [18F]fluoro-glycoconjugates via oxime formation
|
Keinänen, Outi
|
|
2018
|
136-137 |
C |
p. 27-35
|
artikel
|
| 236 |
Enhancing the accumulation level of 3-[18F]fluoro-L-α-methyltyrosine in tumors by preloading probenecid
|
Kanai, Ayaka
|
|
|
136-137 |
C |
p. 47-52
|
artikel
|
| 237 |
Enhancing the therapeutic index of [211At]YF2 with iodo pseudo carrier: A simple strategy for reducing accumulation in kidneys, salivary and lacrimal glands
|
Huynh, Truc T.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 238 |
Establishment of a method for in-vivo SPECT/CT imaging analysis of 111In-labeled exendin-4 pancreatic uptake in mice without the need for nephrectomy or a secondary probe
|
Hamamatsu, Keita
|
|
|
136-137 |
C |
p. 22-27
|
artikel
|
| 239 |
Estimation of radiation dosimetry for 68Ga-HBED-CC (PSMA-11) in patients with suspected recurrence of prostate cancer
|
Green, Mark A.
|
|
2017
|
136-137 |
C |
p. 32-35
4 p.
|
artikel
|
| 240 |
Evaluation and selection of a lead diabody for interferon-γ PET imaging
|
Rezazadeh, Farzaneh
|
|
|
136-137 |
C |
p. 162-167
|
artikel
|
| 241 |
Evaluation of a bimodal, matched pair theranostic agent targeting prostate-specific membrane antigen
|
Lewis, Michael R.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 242 |
Evaluation of [225Ac]Ac-DOTA-anti-VLA-4 for targeted alpha therapy of metastatic melanoma
|
Cortez, Angel
|
|
|
136-137 |
C |
p. 62-72
|
artikel
|
| 243 |
Evaluation of a chloride-based 89Zr isolation strategy using a tributyl phosphate (TBP)-functionalized extraction resin
|
Graves, Stephen A.
|
|
|
136-137 |
C |
p. 1-7
|
artikel
|
| 244 |
Evaluation of acute intravenous toxicity of HEPES: Is Good's buffer good and safe enough for clinical utilization in nuclear medicine?
|
Guleria, Mohini
|
|
|
136-137 |
C |
p.
|
artikel
|
| 245 |
Evaluation of affibody molecule-based PNA-mediated radionuclide pretargeting: Development of an optimized conjugation protocol and 177Lu labeling
|
Altai, Mohamed
|
|
2017
|
136-137 |
C |
p. 1-9
9 p.
|
artikel
|
| 246 |
Evaluation of a novel GRPR antagonist for prostate cancer PET imaging: [64Cu]-DOTHA2-PEG-RM26
|
Mansour, Nematallah
|
|
2018
|
136-137 |
C |
p. 31-38
|
artikel
|
| 247 |
Evaluation of a novel hexadentate 1,2-hydroxypyridinone-based acyclic chelate, HOPO-O6-C4, for 43Sc/47Sc, 68Ga, and 45Ti radiopharmaceuticals
|
Carbo-Bague, Imma
|
|
|
136-137 |
C |
p.
|
artikel
|
| 248 |
Evaluation of a novel radiotracer for positron emission tomography imaging of reactive oxygen species in the central nervous system
|
Wilson, Alan A.
|
|
2017
|
136-137 |
C |
p. 14-20
7 p.
|
artikel
|
| 249 |
Evaluation of 134Ce as a PET imaging surrogate for antibody drug conjugates incorporating 225Ac
|
Bailey, Tyler A.
|
|
|
136-137 |
C |
p. 28-36
|
artikel
|
| 250 |
Evaluation of [11C]KB631 as a PET tracer for in vivo visualisation of HDAC6 in B16.F10 melanoma
|
Vermeulen, Koen
|
|
|
136-137 |
C |
p. 1-11
|
artikel
|
| 251 |
Evaluation of [18F]-ATRi as PET tracer for in vivo imaging of ATR in mouse models of brain cancer
|
Carlucci, Giuseppe
|
|
2017
|
136-137 |
C |
p. 9-15
7 p.
|
artikel
|
| 252 |
Evaluation of [18F]FDG/[18F]FLT/[18F]FMISO-based micro-positron emission tomography in detection of liver metastasis in human colorectal cancer
|
Jiang, Hao
|
|
2019
|
136-137 |
C |
p. 36-44
|
artikel
|
| 253 |
Evaluation of [18F]FMTEB in Sprague Dawley rats as a PET tracer for metabotropic glutamate receptor 5
|
Krzyczmonik, Anna
|
|
|
136-137 |
C |
p.
|
artikel
|
| 254 |
Evaluation of [18F]FNM biodistribution and dosimetry based on whole-body PET imaging of rats
|
Salabert, Anne-Sophie
|
|
2018
|
136-137 |
C |
p. 1-8
|
artikel
|
| 255 |
Evaluation of [18F]pitavastatin as a positron emission tomography tracer for in vivo organic transporter polypeptide function
|
Yagi, Yusuke
|
|
|
136-137 |
C |
p. 25-31
|
artikel
|
| 256 |
Evaluation of F-537-Tetrazine in a model for brain pretargeting imaging. Comparison to N-(3-[18F] fluoro-5-(1,2,4,5-tetrazin-3-yl)benzyl)propan-1-amine
|
Shalgunov, Vladimir
|
|
|
136-137 |
C |
p.
|
artikel
|
| 257 |
Evaluation of heterotopic ossification maturity using SPECT/CT and PET/CT in preclinical model
|
Dannoon, Shorouk
|
|
|
136-137 |
C |
p.
|
artikel
|
| 258 |
Evaluation of 177Lu[Lu]-CHX-A″-DTPA-6A10 Fab as a radioimmunotherapy agent targeting carbonic anhydrase XII
|
Fiedler, L.
|
|
2018
|
136-137 |
C |
p. 55-62
|
artikel
|
| 259 |
Evaluation of N-(6-[18F]Fluoropyridin-3-yl)glycine PET renography to detect renal function progression in a rat model of diabetic nephropathy
|
Wang, Hongliang
|
|
|
136-137 |
C |
p. 59-65
|
artikel
|
| 260 |
Evaluation of radioiodinated protein conjugates and their potential metabolites containing lysine-urea-glutamate (LuG), PEG and closo-decaborate(2-) as models for targeting astatine-211 to metastatic prostate cancer.
|
Li, Yawen
|
|
|
136-137 |
C |
p. 217-227
|
artikel
|
| 261 |
Evaluation of radio-thin-layer chromatography as an alternative to radio-HPLC for [18F]SynVesT-1 metabolism analysis in rats
|
Balayeva, Tutukhanim
|
|
|
136-137 |
C |
p.
|
artikel
|
| 262 |
Evaluation of sulfone-labeled amino acid derivatives as potential PET agents for cancer imaging
|
Hu, Mei
|
|
|
136-137 |
C |
p.
|
artikel
|
| 263 |
Evaluation of targeting αVβ3 in breast cancers using RGD peptide-based agents
|
Josefsson, Anders
|
|
|
136-137 |
C |
p.
|
artikel
|
| 264 |
Evaluation of the first 44Sc-labeled Affibody molecule for imaging of HER2-expressing tumors
|
Honarvar, Hadis
|
|
2017
|
136-137 |
C |
p. 15-21
7 p.
|
artikel
|
| 265 |
Evaluation of the high affinity [18F]fluoropyridine-candesartan in rats for PET imaging of renal AT1 receptors
|
Abreu Diaz, Aida M.
|
|
|
136-137 |
C |
p. 41-49
|
artikel
|
| 266 |
Evaluation of the α-synuclein PET radiotracer (d3)-[11C]MODAG-001 in pigs
|
Raval, Nakul Ravi
|
|
|
136-137 |
C |
p. 42-48
|
artikel
|
| 267 |
Evaluation of two nucleophilic syntheses routes for the automated synthesis of 6-[18F]fluoro-l-DOPA
|
Pretze, Marc
|
|
2017
|
136-137 |
C |
p. 35-42
8 p.
|
artikel
|
| 268 |
Excitation function and yield for the 103Rh(d,2n)103Pd nuclear reaction: Optimization of the production of palladium-103
|
Manenti, Simone
|
|
2017
|
136-137 |
C |
p. 30-37
|
artikel
|
| 269 |
Excitatory glutamate transporter EAAC1 as an important transporter of N-(2-[18F]fluoropropionyl)-L-glutamate in oncology PET imaging
|
Tang, Caihua
|
|
|
136-137 |
C |
p. 55-62
|
artikel
|
| 270 |
EXIRAD-3D: Fast automated three-dimensional autoradiography
|
Nguyen, Minh Phuong
|
|
|
136-137 |
C |
p. 59-65
|
artikel
|
| 271 |
Expanding LogP: Present possibilities
|
Vraka, Chrysoula
|
|
2018
|
136-137 |
C |
p. 20-32
|
artikel
|
| 272 |
Expanding PET-applications in life sciences with positron-emitters beyond fluorine-18
|
Coenen, Heinz H.
|
|
|
136-137 |
C |
p. 241-269
|
artikel
|
| 273 |
Exploration of the utilization of irreversible cysteine protease inhibitor in FAP-targeted radiopharmaceuticals design to increase tumor residence time
|
Brake, Katie
|
|
|
136-137 |
C |
p.
|
artikel
|
| 274 |
Facile radiochemical separation of clinical-grade 90Y from 90Sr by selective precipitation for targeted radionuclide therapy
|
Chakravarty, Rubel
|
|
2019
|
136-137 |
C |
p. 58-65
|
artikel
|
| 275 |
[18F]BCPP-BF-PET as an imaging tool for mitochondrial dysfunction in diabetic pancreatopathy and nephrotoxicity
|
Tomonari, Yuki
|
|
|
136-137 |
C |
p.
|
artikel
|
| 276 |
[18F]BCPP-EF positron emission tomography of rat ovaries for evaluation of mitochondrial function
|
Tomonari, Yuki
|
|
|
136-137 |
C |
p.
|
artikel
|
| 277 |
Feasibility of myocardial PET imaging using a benzylguanidine analog: meta-(3-[18F]fluoropropyl)benzylguanidine ([18F]mFPBG)
|
Woo, Sang-Keun
|
|
2018
|
136-137 |
C |
p. 63-70
|
artikel
|
| 278 |
Feasibility studies of radioiodinated pyridyl benzofuran derivatives as potential SPECT imaging agents for prion deposits in the brain
|
Fuchigami, Takeshi
|
|
|
136-137 |
C |
p. 41-48
|
artikel
|
| 279 |
[18F]FDG and [11C]PK11195 PET imaging in the evaluation of brown adipose tissue - effects of cold and pharmacological stimuli and their association with crotamine intake in a male mouse model
|
de Paula Faria, Daniele
|
|
|
136-137 |
C |
p.
|
artikel
|
| 280 |
[18F]F-DPA for the detection of activated microglia in a mouse model of Alzheimer's disease
|
Keller, Thomas
|
|
2018
|
136-137 |
C |
p. 1-9
|
artikel
|
| 281 |
2-[18F]FELP, a novel LAT1-specific PET tracer, for the discrimination between glioblastoma, radiation necrosis and inflammation
|
Verhoeven, Jeroen
|
|
|
136-137 |
C |
p. 9-16
|
artikel
|
| 282 |
18F-fluoro-2-deoxyglucose PET informs neutrophil accumulation and activation in lipopolysaccharide-induced acute lung injury
|
Rodrigues, Rosana S.
|
|
2017
|
136-137 |
C |
p. 52-62
11 p.
|
artikel
|
| 283 |
[18F]FMISO-PET imaging reveals the role of hypoxia severity in checkpoint blockade response
|
McNeal, Kaytlyn C.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 284 |
[18F]-GE-179 positron emission tomography (PET) tracer for N-methyl-d-aspartate receptors: One-pot synthesis and preliminary micro-PET study in a rat model of MCAO
|
Zhou, Weiyan
|
|
2018
|
136-137 |
C |
p. 45-55
|
artikel
|
| 285 |
First-in-human healthy volunteer dosimetry studies of the excitatory amino acid transporter 2 (EAAT2) PET imaging tracer methyl N
4-(7-[18F]fluoro-9H-fluoren-2-yl)asparaginate, [18F]RP-115
|
Chao, Chih-Kai
|
|
|
136-137 |
C |
p.
|
artikel
|
| 286 |
18F–labeled estradiol derivative for targeting estrogen receptor-expressing breast cancer
|
Xu, Duo
|
|
2018
|
136-137 |
C |
p. 48-55
|
artikel
|
| 287 |
18F-labeled ethisterone derivative for progesterone receptor targeted PET imaging of breast cancer
|
Gao, Fei
|
|
2019
|
136-137 |
C |
p. 62-69
|
artikel
|
| 288 |
18F-labeled norepinephrine transporter tracer [18F]NS12137: radiosynthesis and preclinical evaluation
|
Kirjavainen, Anna K.
|
|
2018
|
136-137 |
C |
p. 39-46
|
artikel
|
| 289 |
18F-Labeled perfluorocarbon droplets for positron emission tomography imaging
|
Amir, Nagina
|
|
2017
|
136-137 |
C |
p. 27-33
7 p.
|
artikel
|
| 290 |
18F-labeling and initial in vivo evaluation of a Hitomi peptide for imaging tissue transglutaminase 2
|
Ackermann, Uwe
|
|
|
136-137 |
C |
p.
|
artikel
|
| 291 |
18F-labelled BODIPY dye as a dual imaging agent: Radiofluorination and applications in PET and optical imaging
|
Kwon, Young-Do
|
|
|
136-137 |
C |
p. 22-36
|
artikel
|
| 292 |
Fluorine-18 labeled diphenyl sulfide derivatives for imaging serotonin transporter (SERT) in the brain
|
Zhang, Yan
|
|
2018
|
136-137 |
C |
p. 1-9
|
artikel
|
| 293 |
Fluorine-18 labeled poly (ADP-ribose) polymerase1 inhibitor as a potential alternative to 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography in oral cancer imaging
|
Demétrio de Souza França, Paula
|
|
|
136-137 |
C |
p. 80-87
|
artikel
|
| 294 |
Fluselenamyl: Evaluation of radiation dosimetry in mice and pharmacokinetics in brains of non-human primate
|
Sundaram, G.S.M.
|
|
|
136-137 |
C |
p. 33-40
|
artikel
|
| 295 |
From the target cell theory to a more integrated view of radiobiology in Targeted radionuclide therapy: The Montpellier group's experience
|
Pouget, Jean-Pierre
|
|
|
136-137 |
C |
p. 53-64
|
artikel
|
| 296 |
[18F]RPS-544: A PET tracer for imaging the chemokine receptor CXCR4
|
Amor-Coarasa, Alejandro
|
|
2018
|
136-137 |
C |
p. 37-44
|
artikel
|
| 297 |
Fully automated dual-run manufacturing of [11C]PIB on FASTlab
|
Nair, Manoj
|
|
|
136-137 |
C |
p.
|
artikel
|
| 298 |
GABAa receptor density alterations revealed in a mouse model of early moderate prenatal ethanol exposure using [18F]AH114726
|
Nguyen, Van T.
|
|
|
136-137 |
C |
p. 44-51
|
artikel
|
| 299 |
[68Ga]Ga-DOTA-TOC PET/CT in the localization of head and neck paraganglioma compared with [18F]FDOPA PET/CT and [123I]MIBG SPECT/CT
|
Kroiss, Alexander Stephan
|
|
2019
|
136-137 |
C |
p. 47-53
|
artikel
|
| 300 |
68Ga[Ga]-Galmydar: Biodistribution and radiation dosimetry studies in rodents
|
Sivapackiam, Jothilingam
|
|
2018
|
136-137 |
C |
p. 29-35
|
artikel
|
| 301 |
[68Ga]Ga-HBED-CC-DiAsp: A new renal function imaging agent
|
Shi, Shengyu
|
|
|
136-137 |
C |
p. 17-24
|
artikel
|
| 302 |
[68Ga]Ga-iPSMA-Lys3-Bombesin: Biokinetics, dosimetry and first patient PET/CT imaging
|
Rivera-Bravo, Belén
|
|
|
136-137 |
C |
p. 54-60
|
artikel
|
| 303 |
[68Ga]Ga-NOTA-MAL-Cys39-exendin-4, a potential GLP-1R targeted PET tracer for the detection of insulinoma
|
Zhang, Pengjun
|
|
|
136-137 |
C |
p. 19-24
|
artikel
|
| 304 |
67Ga-labeled deferoxamine derivatives for imaging bacterial infection: Preparation and screening of functionalized siderophore complexes
|
Ioppolo, Joseph A.
|
|
2017
|
136-137 |
C |
p. 32-41
10 p.
|
artikel
|
| 305 |
68Ga-labeled PET tracers for targeting tumor hypoxia: Role of bifunctional chelators on pharmacokinetics
|
Mittal, Sweety
|
|
|
136-137 |
C |
p. 61-67
|
artikel
|
| 306 |
68Ga-labelled-exendin-4: New GLP1R targeting agents for imaging pancreatic β-cell and insulinoma
|
Li, Linlin
|
|
|
136-137 |
C |
p. 87-96
|
artikel
|
| 307 |
68Ga-labelled NOTA-RGD-GE11 peptide for dual integrin and EGFR-targeted tumour imaging
|
Chen, Chien-Jen
|
|
2019
|
136-137 |
C |
p. 22-30
|
artikel
|
| 308 |
Gallium-68 labeled Ubiquicidin derived octapeptide as a potential infection imaging agent
|
Bhatt, Jyotsna
|
|
|
136-137 |
C |
p. 47-53
|
artikel
|
| 309 |
Gastrin-releasing peptide receptor as theranostic target in estrogen-receptor positive breast cancer: A preclinical study of the theranostic pair [55Co]Co- and [177Lu]Lu-DOTA-RM26
|
Baun, Christina
|
|
|
136-137 |
C |
p.
|
artikel
|
| 310 |
[68Ga]/[90Y]FAPI-46: Automated production and analytical validation of a theranostic pair
|
Nader, M.
|
|
|
136-137 |
C |
p. 37-44
|
artikel
|
| 311 |
Gefitinib enhances radiotherapeutic effects of 131I–hEGF targeted to EGFR by increasing tumor uptake of hEGF in tumor xenografts
|
Xia, Lu
|
|
2017
|
136-137 |
C |
p. 63-68
6 p.
|
artikel
|
| 312 |
GMP production of [68Ga]Ga-BOT5035 for imaging of liver fibrosis in microdosing phase 0 study
|
Velikyan, Irina
|
|
|
136-137 |
C |
p. 73-85
|
artikel
|
| 313 |
Gold nanoparticles meet medical radionuclides
|
Daems, Noami
|
|
|
136-137 |
C |
p. 61-90
|
artikel
|
| 314 |
Healthy brain aging assessed with [18F]FDG and [11C]UCB-J PET
|
Andersen, Katrine B.
|
|
|
136-137 |
C |
p. 52-58
|
artikel
|
| 315 |
High-throughput radio-TLC analysis
|
Wang, Jia
|
|
|
136-137 |
C |
p. 41-48
|
artikel
|
| 316 |
High-yield cyclotron production of 203Pb using a sealed 205Tl solid target
|
Nelson, Bryce J.B.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 317 |
HMGB1 expression in leukocytes as a biomarker of cellular damage induced by [99mTc]Tc-HMPAO-labelling procedure: A quality control study
|
Follacchio, Giulia Anna
|
|
|
136-137 |
C |
p. 94-100
|
artikel
|
| 318 |
How green are radiopharmaceutical sciences?
|
Pichler, Verena
|
|
|
136-137 |
C |
p.
|
artikel
|
| 319 |
HRD1 attenuates the high uptake of [18F]FDG in hepatocellular carcinoma PET imaging
|
Li, Ai-Mei
|
|
|
136-137 |
C |
p. 27-34
|
artikel
|
| 320 |
Human biodistribution and dosimetry of [18F]nifene, an α4β2* nicotinic acetylcholine receptor PET tracer
|
Betthauser, Tobey J.
|
|
2017
|
136-137 |
C |
p. 7-11
|
artikel
|
| 321 |
Human biodistribution, dosimetry, radiosynthesis and quality control of the bile acid PET tracer [N-methyl-11C]cholylsarcosine
|
Frisch, Kim
|
|
2019
|
136-137 |
C |
p. 55-61
|
artikel
|
| 322 |
IAEA activities to support the member states in the production of targeted alpha therapy radiopharmaceuticals
|
Jalilian, A.R.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 323 |
Identification and quantitative structure–activity relationship assessment of trace chemical impurities contained in the therapeutic formulation of [64Cu]Cu-ATSM
|
Igarashi, Chika
|
|
|
136-137 |
C |
p. 10-15
|
artikel
|
| 324 |
131I-labeled chitosan hydrogels for radioembolization: A preclinical study in small animals
|
Hwang, Hyosook
|
|
2017
|
136-137 |
C |
p. 16-23
8 p.
|
artikel
|
| 325 |
Imaging assessment of cardioprotection mediated by a dodecafluoropentane oxygen-carrier administered during myocardial infarction
|
Liu, Zhonglin
|
|
2019
|
136-137 |
C |
p. 67-77
|
artikel
|
| 326 |
Imaging diabetic cardiomyopathy in a type 1 diabetic rat model using 18F-FEPPA PET
|
Hsieh, Hsin-Hua
|
|
|
136-137 |
C |
p.
|
artikel
|
| 327 |
Imaging niacin trafficking with positron emission tomography reveals in vivo monocarboxylate transporter distribution
|
Bongarzone, Salvatore
|
|
|
136-137 |
C |
p. 24-33
|
artikel
|
| 328 |
Imaging of isoproterenol-induced myocardial injury with 18F labeled fluoroglucaric acid in a rat model
|
Houson, Hailey A.
|
|
2018
|
136-137 |
C |
p. 9-15
|
artikel
|
| 329 |
Imaging of microglia in post-stroke inflammation
|
Wang, Ze
|
|
|
136-137 |
C |
p.
|
artikel
|
| 330 |
Imaging of the third gasotransmitter hydrogen sulfide using 99mTc-labeled alpha-hydroxy acids
|
Park, Ji Yong
|
|
|
136-137 |
C |
p. 28-35
|
artikel
|
| 331 |
Imaging thrombosis with 99mTc-labeled RAM.1-antibody in vivo
|
Ouadi, Ali
|
|
2018
|
136-137 |
C |
p. 21-27
|
artikel
|
| 332 |
[131I]MIBG exports via MRP transporters and inhibition of the MRP transporters improves accumulation of [131I]MIBG in neuroblastoma
|
Kobayashi, Masato
|
|
|
136-137 |
C |
p. 49-54
|
artikel
|
| 333 |
Iminodiacetic acid as bifunctional linker for dimerization of cyclic RGD peptides
|
Xu, Dong
|
|
2017
|
136-137 |
C |
p. 1-8
8 p.
|
artikel
|
| 334 |
Immuno-imaging of ICAM-1 in tumours by SPECT
|
Mosley, Michael
|
|
|
136-137 |
C |
p. 73-79
|
artikel
|
| 335 |
Immuno-SPECT/PET imaging with radioiodinated anti-PD-L1 antibody to evaluate PD-L1 expression in immune-competent murine models and PDX model of lung adenocarcinoma
|
Wen, Xuejun
|
|
|
136-137 |
C |
p. 44-51
|
artikel
|
| 336 |
Impact of structural alterations on the radiopharmacological profile of 18F-labeled pyrimidines as cyclooxygenase-2 (COX-2) imaging agents
|
Tietz, Ole
|
|
|
136-137 |
C |
p. 9-17
|
artikel
|
| 337 |
Improved production of 76Br, 77Br and 80mBr via CoSe cyclotron targets and vertical dry distillation
|
Ellison, Paul A.
|
|
|
136-137 |
C |
p. 32-36
|
artikel
|
| 338 |
Improved purification of cyclotron [68Ga]GaCl3 for the production of 68Ga radiopharmaceuticals
|
Wang, Ivan E.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 339 |
Improved separation scheme for 44Sc produced by irradiation of natCa targets with 12.8 MeV protons
|
Kurakina, E.S.
|
|
|
136-137 |
C |
p. 22-27
|
artikel
|
| 340 |
Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imaging
|
Ruivo, Eduardo
|
|
|
136-137 |
C |
p. 36-42
|
artikel
|
| 341 |
Improving metabolic stability of fluorine-18 labeled verapamil analogs
|
Raaphorst, Renske M.
|
|
|
136-137 |
C |
p. 47-56
|
artikel
|
| 342 |
111In-DTPA-d-Phe−1-Asp0-d-Phe1-octreotide exhibits higher tumor accumulation and lower renal radioactivity than 111In-DTPA-d-Phe1-octreotide
|
Oshima, Nobuhiro
|
|
2017
|
136-137 |
C |
p. 18-26
9 p.
|
artikel
|
| 343 |
Influence of binding affinity and blood plasma level on cerebral pharmacokinetics and PET imaging characteristics of two novel xanthine PET radioligands for the A1 adenosine receptor
|
Schneider, Daniela
|
|
|
136-137 |
C |
p. 1-8
|
artikel
|
| 344 |
Influence of PEGylation on HER2-targeting retro A9 peptide analogue
|
Yadav, Sushree Arpitabala
|
|
|
136-137 |
C |
p.
|
artikel
|
| 345 |
Influence of transport line material on the molar activity of cyclotron produced [18F]fluoride
|
Savisto, Nina
|
|
|
136-137 |
C |
p. 8-15
|
artikel
|
| 346 |
Inhibition of viability of microorganisms in [18F]-labeled radiopharmaceuticals
|
Jörg, G.
|
|
2017
|
136-137 |
C |
p. 105-113
9 p.
|
artikel
|
| 347 |
Initial insights into the interaction of antibodies radiolabeled with Lutetium-177 and Actinium-225 with tumor microenvironment in experimental human and canine osteosarcoma
|
Giri, Sabeena
|
|
|
136-137 |
C |
p.
|
artikel
|
| 348 |
Intraarticular and intravenous administration of 99MTc-HMPAO-labeled human mesenchymal stem cells (
99M
TC-AH-MSC
S
): In vivo imaging and biodistribution
|
Meseguer-Olmo, Luis
|
|
2017
|
136-137 |
C |
p. 36-42
7 p.
|
artikel
|
| 349 |
Introduction of a fatty acid chain modification to prolong circulatory half-life of a radioligand towards glucose-dependent insulinotropic polypeptide receptor
|
Khalil, Amina
|
|
|
136-137 |
C |
p.
|
artikel
|
| 350 |
Investigating intrinsic radiosensitivity biomarkers to peptide receptor radionuclide therapy with [177Lu]Lu-DOTATATE in a panel of cancer cell lines
|
Delbart, Wendy
|
|
|
136-137 |
C |
p. 68-79
|
artikel
|
| 351 |
Investigating the fate of Zirconium-89 labelled antibody in cynomolgus macaques
|
Sasaki, Takanori
|
|
|
136-137 |
C |
p.
|
artikel
|
| 352 |
Investigation of imaging the somatostatin receptor by opening the blood-brain barrier with melittin – A feasibility study using positron emission tomography and [64Cu]Cu-DOTATATE
|
Andersen, Ida Vang
|
|
|
136-137 |
C |
p.
|
artikel
|
| 353 |
Investigation of 123I production using electron accelerator
|
Avetisyan, Albert
|
|
2017
|
136-137 |
C |
p. 44-47
|
artikel
|
| 354 |
In vitro and in vivo evaluation of the bifunctional chelator NODIA-Me in combination with a prostate-specific membrane antigen targeting vector
|
Läppchen, Tilman
|
|
2018
|
136-137 |
C |
p. 45-54
|
artikel
|
| 355 |
In vitro binding affinity vs. in vivo site occupancy: A PET study of four diastereomers of dihydrotetrabenazine (DTBZ) in monkey brain
|
Kilbourn, Michael R.
|
|
|
136-137 |
C |
p. 38-42
|
artikel
|
| 356 |
In vitro cytotoxicity of Auger electron-emitting [67Ga]Ga-trastuzumab
|
Othman, Muhamad Faiz bin
|
|
|
136-137 |
C |
p. 57-64
|
artikel
|
| 357 |
In vitro evaluation of [3H]PI-2620 and structural derivatives in non-Alzheimer's tauopathies
|
Varlow, Cassis
|
|
|
136-137 |
C |
p.
|
artikel
|
| 358 |
In vitro uptake and metabolism of [14C]acetate in rabbit atherosclerotic arteries: biological basis for atherosclerosis imaging with [11C]acetate
|
Yamasaki, Kazuaki
|
|
2018
|
136-137 |
C |
p. 21-25
|
artikel
|
| 359 |
In vivo imaging characterization and anticancer efficacy of a novel HER2 affibody and pemetrexed conjugate in lung cancer model
|
Jiao, Honglei
|
|
2019
|
136-137 |
C |
p. 31-39
|
artikel
|
| 360 |
In vivo tracking of [89Zr]Zr-labeled engineered extracellular vesicles by PET reveals organ-specific biodistribution based upon the route of administration
|
Patel, Shil
|
|
|
136-137 |
C |
p. 20-30
|
artikel
|
| 361 |
In vivo validation of 68Ga-labeled AMD3100 conjugates for PET imaging of CXCR4
|
Renard, Isaline
|
|
|
136-137 |
C |
p.
|
artikel
|
| 362 |
Is logP truly dead?
|
Kilbourn, Michael R.
|
|
2017
|
136-137 |
C |
p. 41-42
2 p.
|
artikel
|
| 363 |
Issues in preclinical radiopharmaceutical research: Significance, relevance and reproducibility
|
Kilbourn, Michael R.
|
|
2018
|
136-137 |
C |
p. 52-55
|
artikel
|
| 364 |
Kinetic isotope effects and synthetic strategies for deuterated carbon-11 and fluorine-18 labelled PET radiopharmaceuticals
|
Klenner, Mitchell A.
|
|
|
136-137 |
C |
p. 112-147
|
artikel
|
| 365 |
Kinetic modeling and non-invasive approach for translocator protein quantification with 11C-DPA-713
|
Yasuno, Fumihiko
|
|
|
136-137 |
C |
p. 76-84
|
artikel
|
| 366 |
Kit-based preparation of [68Ga]Ga-P16-093 (PSMA-093) using different commercial 68Ge/68Ga generators
|
Hong, Haiyan
|
|
|
136-137 |
C |
p. 1-9
|
artikel
|
| 367 |
Know thy tumour: Biomarkers to improve treatment of molecular radionuclide therapy
|
O'Neill, Edward
|
|
|
136-137 |
C |
p. 44-53
|
artikel
|
| 368 |
Labeling single domain antibody fragments with 18F using a novel residualizing prosthetic agent — N-succinimidyl 3-(1-(2-(2-(2-(2-[18F]fluoroethoxy)ethoxy)ethoxy)ethyl)-1H-1,2,3-triazol-4-yl)-5-(guanidinomethyl)benzoate
|
Zhou, Zhengyuan
|
|
|
136-137 |
C |
p. 24-35
|
artikel
|
| 369 |
Laminated holmium-166-containing electrospun bandages for use against skin cancer
|
Osipitan, Ositomiwa O.
|
|
|
136-137 |
C |
p. 78-85
|
artikel
|
| 370 |
LogP, a yesterday's value?
|
Vraka, Chrysoula
|
|
2017
|
136-137 |
C |
p. 1-10
|
artikel
|
| 371 |
Longitudinal multimodal monitoring of transplanted islet β-cells
|
Michelotti, Filippo C.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 372 |
Longitudinal multi-tracer imaging of hepatocellular carcinoma identifies novel stage- and oncogene-specific changes
|
Teuter, Mari
|
|
|
136-137 |
C |
p.
|
artikel
|
| 373 |
Long-term biodistribution study of HPMA-ran-LMA copolymers in vivo by means of 131I-labeling
|
Wagener, Karolin
|
|
2018
|
136-137 |
C |
p. 59-66
|
artikel
|
| 374 |
Matched-pair, 86Y/90Y-labeled, bivalent RGD/bombesin antagonist, [RGD-Glu-[DO3A]-6-Ahx-RM2], as a potential theranostic agent for prostate cancer
|
Bandara, Nilantha
|
|
|
136-137 |
C |
p. 71-77
|
artikel
|
| 375 |
Metabolic characteristics of [18F]fluoroboronotyrosine (FBY) PET in malignant brain tumors
|
Kong, Ziren
|
|
|
136-137 |
C |
p. 80-87
|
artikel
|
| 376 |
Methods and techniques for in vitro subcellular localization of radiopharmaceuticals and radionuclides
|
Costa, Ines M.
|
|
|
136-137 |
C |
p. 18-29
|
artikel
|
| 377 |
MicroPET imaging of vesicular monoamine transporter 2 revealed the potentiation of (+)-dihydrotetrabenazine on MPTP-induced degeneration of dopaminergic neurons
|
Xu, Yingjiao
|
|
|
136-137 |
C |
p. 9-18
|
artikel
|
| 378 |
Microscale radiosynthesis, preclinical imaging and dosimetry study of [18F]AMBF3-TATE: A potential PET tracer for clinical imaging of somatostatin receptors
|
Lisova, Ksenia
|
|
2018
|
136-137 |
C |
p. 36-44
|
artikel
|
| 379 |
Microwave-assisted synthesis of [52Mn]Mn-porphyrins: Applications in cell and liposome radiolabelling
|
Gawne, Peter J.
|
|
|
136-137 |
C |
p. 6-17
|
artikel
|
| 380 |
Mini-review: Antibody-PET of receptor tyrosine kinase interplay and heterogeneity
|
Chegu, Anusha
|
|
|
136-137 |
C |
p. 70-75
|
artikel
|
| 381 |
Mini-review: Targeted radiopharmaceuticals incorporating reversible, low molecular weight albumin binders
|
Brandt, Marie
|
|
2019
|
136-137 |
C |
p. 46-52
|
artikel
|
| 382 |
Modelling the internalisation process of prostate cancer cells for PSMA-specific ligands
|
Winter, Gordon
|
|
2019
|
136-137 |
C |
p. 20-25
|
artikel
|
| 383 |
Molar activity – The keystone in 11C-radiochemistry: An explorative study using the gas phase method
|
Pichler, Verena
|
|
2018
|
136-137 |
C |
p. 21-26
|
artikel
|
| 384 |
Molecular imaging and treatment of PSMA-positive prostate cancer with 99mTc radiolabeled aptamer-siRNA chimeras
|
Jiao, Yuying
|
|
|
136-137 |
C |
p. 28-37
|
artikel
|
| 385 |
Molecular imaging of microbiota-gut-brain axis: searching for the right targeted probe for the right target and disease
|
Giron, Maria Cecilia
|
|
|
136-137 |
C |
p. 72-77
|
artikel
|
| 386 |
Molecular imaging of platelet-derived growth factor receptor-alpha (PDGFRα) in papillary thyroid cancer using immuno-PET
|
Wagner, Michael
|
|
2018
|
136-137 |
C |
p. 51-58
|
artikel
|
| 387 |
Monitoring of macrophage accumulation in statin-treated atherosclerotic mouse model using sodium iodide symporter imaging system
|
Yoo, Ran Ji
|
|
2017
|
136-137 |
C |
p. 45-51
7 p.
|
artikel
|
| 388 |
Monoanionic 99mTc-tricarbonyl-aminopolycarboxylate complexes with uncharged pendant groups: Radiosynthesis and evaluation as potential renal tubular tracers
|
Lipowska, Malgorzata
|
|
2017
|
136-137 |
C |
p. 48-55
|
artikel
|
| 389 |
[99mTc]duramycin for cell death imaging: Impact of kit formulation, purification and species difference
|
Palmieri, Luca
|
|
2018
|
136-137 |
C |
p. 1-9
|
artikel
|
| 390 |
99mTc labeled D(LPR): A novel retro-inverso peptide for VEGF receptor-1 targeted tumor imaging
|
Rezazadeh, Farzaneh
|
|
|
136-137 |
C |
p. 54-62
|
artikel
|
| 391 |
99mTc-labeled PSMA inhibitor: Biokinetics and radiation dosimetry in healthy subjects and imaging of prostate cancer tumors in patients
|
Santos-Cuevas, Clara
|
|
2017
|
136-137 |
C |
p. 1-6
6 p.
|
artikel
|
| 392 |
99mTc-labeling and evaluation of a HYNIC modified small-molecular inhibitor of prostate-specific membrane antigen
|
Xu, Xiaoping
|
|
2017
|
136-137 |
C |
p. 69-75
7 p.
|
artikel
|
| 393 |
99mTc-3PRGD2 scintigraphy to stage liver fibrosis and evaluate reversal after fibrotic stimulus withdrawn
|
Zhang, Xin
|
|
2017
|
136-137 |
C |
p. 44-49
|
artikel
|
| 394 |
[99mTc]Tc-duramycin, a potential molecular probe for early prediction of tumor response after chemotherapy
|
Li, Yi
|
|
2018
|
136-137 |
C |
p. 18-25
|
artikel
|
| 395 |
[99mTc]Tc-HYNIC-RM2: A potential SPECT probe targeting GRPR expression in prostate cancers
|
Vats, Kusum
|
|
|
136-137 |
C |
p.
|
artikel
|
| 396 |
[99mTc]Tc-iPSMA SPECT brain imaging as a potential specific diagnosis of metastatic brain tumors and high-grade gliomas
|
Vallejo-Armenta, Paola
|
|
|
136-137 |
C |
p. 1-8
|
artikel
|
| 397 |
Multimodality labeling strategies for the investigation of nanocrystalline cellulose biodistribution in a mouse model of breast cancer
|
Sarparanta, Mirkka
|
|
|
136-137 |
C |
p. 1-12
|
artikel
|
| 398 |
NANOCIS®: Possible errors in the summary of product characteristics quality control method and a suggested alternative method
|
Paludan, J.P.
|
|
|
136-137 |
C |
p. 1-5
|
artikel
|
| 399 |
Nanozeolite bioconjugates labeled with 223Ra for targeted alpha therapy
|
Piotrowska, Agata
|
|
2017
|
136-137 |
C |
p. 10-18
|
artikel
|
| 400 |
Neutron-activatable radionuclide cancer therapy using graphene oxide nanoplatelets
|
Kim, Junghyun
|
|
2017
|
136-137 |
C |
p. 42-48
7 p.
|
artikel
|
| 401 |
Neutron-activated theranostic radionuclides for nuclear medicine
|
Tan, Hun Yee
|
|
|
136-137 |
C |
p. 55-68
|
artikel
|
| 402 |
New method for production of 155Tb via 155Dy by irradiation of natGd by medium energy alpha particles
|
Moiseeva, A.N.
|
|
|
136-137 |
C |
p. 52-61
|
artikel
|
| 403 |
New potent A1 adenosine receptor radioligands for positron emission tomography
|
Kreft, Sabrina
|
|
2017
|
136-137 |
C |
p. 69-77
9 p.
|
artikel
|
| 404 |
News ways of understanding the complex biology of diabetes using PET
|
Eriksson, O.
|
|
|
136-137 |
C |
p. 65-71
|
artikel
|
| 405 |
N-(4-[18F]fluorobenzyl)cholylglycine, a novel tracer for PET of enterohepatic circulation of bile acids: Radiosynthesis and proof-of-concept studies in rats
|
Frisch, Kim
|
|
2018
|
136-137 |
C |
p. 56-62
|
artikel
|
| 406 |
N-(4-[18F]fluorobenzyl)cholylglycine, a potential tracer for positron emission tomography of enterohepatic circulation and drug-induced inhibition of ileal bile acid transport. A proof-of-concept PET/CT study in pigs
|
Frisch, Kim
|
|
|
136-137 |
C |
p. 49-57
|
artikel
|
| 407 |
N-[18F]-FluoropropylJDTic for κ-opioid receptor PET imaging: Radiosynthesis, pre-clinical evaluation, and metabolic investigation in comparison with parent JDTic
|
Schmitt, Sébastien
|
|
2017
|
136-137 |
C |
p. 50-61
12 p.
|
artikel
|
| 408 |
Nicotinic acetylcholine receptor imaging with [18F]ASEM for skeletal muscle denervation: A novel assessment for peripheral neuromuscular disorders
|
Park, Jae Sung
|
|
|
136-137 |
C |
p.
|
artikel
|
| 409 |
Non-invasive immunoPET imaging of PD-L1 using anti-PD-L1-B11 in breast cancer and melanoma tumor model
|
Bansal, Aditya
|
|
|
136-137 |
C |
p. 4-11
|
artikel
|
| 410 |
Noninvasively visualize the expression of LAPTM4B protein using a novel 18F-labeled peptide PET probe in hepatocellular carcinoma
|
Ren, Yunyan
|
|
|
136-137 |
C |
p. 52-60
|
artikel
|
| 411 |
[No title]
|
Gott, Matthew
|
|
|
136-137 |
C |
p. 32
|
artikel
|
| 412 |
Novel application of [18F]DPA714 for visualizing the pulmonary inflammation process of SARS-CoV-2-infection in rhesus monkeys (Macaca mulatta)
|
Meijer, Lisette
|
|
|
136-137 |
C |
p. 1-8
|
artikel
|
| 413 |
Novel dibutyl ether resin for the purification of the Auger emitter antimony-119 from tin targets
|
Grundmane, Aivija
|
|
|
136-137 |
C |
p.
|
artikel
|
| 414 |
Novel methods for the quantification of toxic, residual phase transfer catalyst in fluorine-18 labeled radiotracers
|
Blevins, David W.
|
|
|
136-137 |
C |
p. 41-48
|
artikel
|
| 415 |
Novel O-[11C]-methylated derivatives of the neprilysin inhibitor sacubitril: Radiosynthesis, autoradiography and plasma stability evaluation
|
Teyssier, Valentin R.
|
|
|
136-137 |
C |
p. 34-44
|
artikel
|
| 416 |
Novel pyridine-containing azacrownethers for the chelation of therapeutic bismuth radioisotopes: Complexation study, radiolabeling, serum stability and biodistribution
|
Egorova, B.V.
|
|
2018
|
136-137 |
C |
p. 1-10
|
artikel
|
| 417 |
Novel radiogallium-labeled pyridyl benzofuran derivative for detection of amylin aggregates in pancreas
|
Watanabe, Hiroyuki
|
|
|
136-137 |
C |
p. 93-97
|
artikel
|
| 418 |
Nuclear data for production and medical application of radionuclides: Present status and future needs
|
Qaim, Syed M.
|
|
2017
|
136-137 |
C |
p. 31-49
19 p.
|
artikel
|
| 419 |
Obituary: P. August Schubiger, PhD (1945–2024)
|
Schibli, Roger
|
|
|
136-137 |
C |
p.
|
artikel
|
| 420 |
O-(2-18F-fluoroethyl)-l-tyrosine (18F-FET) uptake in insulinoma: first results from a xenograft mouse model and from human
|
Imperiale, Alessio
|
|
2017
|
136-137 |
C |
p. 21-28
8 p.
|
artikel
|
| 421 |
On-cartridge preparation and evaluation of 68Ga-, 89Zr- and 64Cu-precursors for cell radiolabelling
|
Socan, A.
|
|
2019
|
136-137 |
C |
p. 23-31
|
artikel
|
| 422 |
One-pot enzymatic synthesis of l-[3-11C]lactate for pharmacokinetic analysis of lactate metabolism in rat brain
|
Temma, Takashi
|
|
|
136-137 |
C |
p. 28-33
|
artikel
|
| 423 |
One-pot synthesis and biodistribution of fluorine-18 labeled serum albumin for vascular imaging
|
Basuli, Falguni
|
|
|
136-137 |
C |
p. 63-70
|
artikel
|
| 424 |
One-step 18F-fluorination of smart positron emission tomography tracer for sensing furin activity in tumors
|
Zhao, Xueyu
|
|
|
136-137 |
C |
p. 72-79
|
artikel
|
| 425 |
On the applicability of [18F]FBPA to predict L-BPA concentration after amino acid preloading in HuH-7 liver tumor model and the implication for liver boron neutron capture therapy
|
Grunewald, Catrin
|
|
2017
|
136-137 |
C |
p. 83-89
7 p.
|
artikel
|
| 426 |
On the consensus nomenclature rules for radiopharmaceutical chemistry – Reconsideration of radiochemical conversion
|
Herth, Matthias M.
|
|
|
136-137 |
C |
p. 19-21
|
artikel
|
| 427 |
Optimization of solid-phase extraction (SPE) in the preparation of [18F]D3FSP: A new PET imaging agent for mapping Aβ plaques
|
Yao, Xinyue
|
|
2019
|
136-137 |
C |
p. 54-64
|
artikel
|
| 428 |
Organic cation transporter 3 mediates the non-norepinephrine transporter driven uptake of meta-[211At]astato-benzylguanidine
|
Ohshima, Yasuhiro
|
|
|
136-137 |
C |
p. 44-51
|
artikel
|
| 429 |
Outside Back Cover
|
|
|
|
136-137 |
C |
p. OBC
|
artikel
|
| 430 |
Outside Back Cover
|
|
|
|
136-137 |
C |
p. OBC
|
artikel
|
| 431 |
Outside Back Cover
|
|
|
|
136-137 |
C |
p. OBC
|
artikel
|
| 432 |
Outside Back Cover
|
|
|
|
136-137 |
C |
p. OBC
|
artikel
|
| 433 |
Outside Back Cover
|
|
|
|
136-137 |
C |
p. OBC
|
artikel
|
| 434 |
Outside Back Cover
|
|
|
|
136-137 |
C |
p. OBC
|
artikel
|
| 435 |
Outside Back Cover
|
|
|
|
136-137 |
C |
p. OBC
|
artikel
|
| 436 |
Outside Back Cover - Graphical abstract TOC
|
|
|
|
136-137 |
C |
p. OBC
|
artikel
|
| 437 |
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
|
|
|
|
136-137 |
C |
p. OBC
|
artikel
|
| 438 |
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
|
|
|
|
136-137 |
C |
p. OBC
|
artikel
|
| 439 |
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
|
|
|
|
136-137 |
C |
p. OBC
|
artikel
|
| 440 |
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
|
|
|
|
136-137 |
C |
p. OBC
|
artikel
|
| 441 |
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
|
|
|
|
136-137 |
C |
p. OBC
|
artikel
|
| 442 |
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
|
|
|
|
136-137 |
C |
p. OBC
|
artikel
|
| 443 |
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
|
|
|
|
136-137 |
C |
p. OBC
|
artikel
|
| 444 |
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
|
|
|
|
136-137 |
C |
p. OBC
|
artikel
|
| 445 |
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
|
|
|
|
136-137 |
C |
p. OBC
|
artikel
|
| 446 |
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
|
|
|
|
136-137 |
C |
p.
|
artikel
|
| 447 |
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
|
|
|
|
136-137 |
C |
p.
|
artikel
|
| 448 |
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
|
|
|
|
136-137 |
C |
p.
|
artikel
|
| 449 |
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
|
|
|
|
136-137 |
C |
p.
|
artikel
|
| 450 |
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
|
|
|
|
136-137 |
C |
p. OBC
|
artikel
|
| 451 |
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
|
|
|
|
136-137 |
C |
p.
|
artikel
|
| 452 |
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
|
|
|
|
136-137 |
C |
p.
|
artikel
|
| 453 |
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
|
|
|
|
136-137 |
C |
p.
|
artikel
|
| 454 |
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
|
|
|
|
136-137 |
C |
p.
|
artikel
|
| 455 |
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
|
|
|
|
136-137 |
C |
p.
|
artikel
|
| 456 |
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
|
|
|
|
136-137 |
C |
p.
|
artikel
|
| 457 |
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
|
|
|
|
136-137 |
C |
p.
|
artikel
|
| 458 |
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
|
|
|
|
136-137 |
C |
p.
|
artikel
|
| 459 |
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
|
|
|
|
136-137 |
C |
p.
|
artikel
|
| 460 |
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information
|
|
|
|
136-137 |
C |
p.
|
artikel
|
| 461 |
Overcoming nephrotoxicity in peptide receptor radionuclide therapy using [177Lu]Lu-DOTA-TATE for the treatment of neuroendocrine tumours
|
Geenen, Lorain
|
|
|
136-137 |
C |
p. 1-11
|
artikel
|
| 462 |
Pancreas and liver uptake of new radiolabeled incretins (GLP-1 and Exendin-4) in models of diet-induced and diet-restricted obesity
|
Seo, Daniele
|
|
2017
|
136-137 |
C |
p. 57-64
|
artikel
|
| 463 |
Passive and receptor mediated brain delivery of an anti-GFAP nanobody
|
Meier, Silvio R.
|
|
|
136-137 |
C |
p. 128-134
|
artikel
|
| 464 |
212Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models
|
Kasten, Benjamin B.
|
|
2018
|
136-137 |
C |
p. 67-73
|
artikel
|
| 465 |
Perspectives on nuclear chemistry, radiochemistry, PET/SPECT imaging and radiotherapy
|
Bongarzone, Salvatore
|
|
|
136-137 |
C |
p. 66-67
|
artikel
|
| 466 |
PET [11C]acetate is also a perfusion tracer for kidney evaluation purposes
|
Normand, Gabrielle
|
|
|
136-137 |
C |
p. 10-14
|
artikel
|
| 467 |
PET/CT with 18F–choline: Physiological whole bio-distribution in male and female subjects and diagnostic pitfalls on 1000 prostate cancer patients
|
Calabria, Ferdinando
|
|
2017
|
136-137 |
C |
p. 40-54
15 p.
|
artikel
|
| 468 |
PET imaging of 64Cu-DOTA-scFv-anti-PSMA lipid nanoparticles (LNPs): Enhanced tumor targeting over anti-PSMA scFv or untargeted LNPs
|
Wong, Patty
|
|
2017
|
136-137 |
C |
p. 62-68
|
artikel
|
| 469 |
PET imaging of the anticancer drug candidate [11C]trimebutine in a rat glioma model
|
Lin, Jia-zhe
|
|
|
136-137 |
C |
p.
|
artikel
|
| 470 |
PET imaging with [18F]FP-(+)-DTBZ in 6-OHDA-induced partial and full unilaterally-lesioned model rats of Parkinson's disease and the correlations to the biological data
|
Tang, Jie
|
|
|
136-137 |
C |
p. 1-9
|
artikel
|
| 471 |
PET measurement of “GABA shift” in the rat brain: A preclinical application of bolus plus constant infusion paradigm of [18F]flumazenil
|
Kim, Wook
|
|
2017
|
136-137 |
C |
p. 30-34
5 p.
|
artikel
|
| 472 |
PET studies in non-human primates: Choosing drug doses
|
Kilbourn, Michael R.
|
|
2017
|
136-137 |
C |
p. 1-3
|
artikel
|
| 473 |
Plasma pharmacokinetic and metabolism of [18F]THK-5317 are dependent on sex
|
Mairinger, Severin
|
|
|
136-137 |
C |
p. 28-32
|
artikel
|
| 474 |
p-NCS-Bn-NODAGA as a bifunctional chelator for radiolabeling with the 186Re/99mTc-tricarbonyl core: Radiochemistry with model complexes and a GRPR-targeting peptide
|
H.A. Kankanamalage, Pavithra
|
|
|
136-137 |
C |
p. 1-9
|
artikel
|
| 475 |
Potent candidates for Targeted Alpha Therapy (TAT)
|
Filosofov, Dmitry
|
|
|
136-137 |
C |
p.
|
artikel
|
| 476 |
Potent candidates for Targeted Auger Therapy: Production and radiochemical considerations
|
Filosofov, Dmitry
|
|
|
136-137 |
C |
p. 1-19
|
artikel
|
| 477 |
Potential for production of medical radionuclides with on-line isotope separation at the ISAC facility at TRIUMF and particular discussion of the examples of 165Er and 155Tb
|
Fiaccabrino, Desiree Erika
|
|
|
136-137 |
C |
p. 81-91
|
artikel
|
| 478 |
Preclinical evaluation of [225Ac]Ac-crown-TATE – An alpha-emitting radiopharmaceutical for neuroendocrine tumors
|
Ingham, Aidan
|
|
|
136-137 |
C |
p.
|
artikel
|
| 479 |
Preclinical evaluation of [225Ac]Ac-PSMA-617 and in vivo effect comparison in combination with [177Lu]Lu-PSMA-617 for prostate cancer
|
Savio, E.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 480 |
Preclinical evaluation of [11C]GW457427 as a tracer for neutrophil elastase
|
Estrada, Sergio
|
|
|
136-137 |
C |
p. 62-71
|
artikel
|
| 481 |
Preclinical evaluation of [18F]cabozantinib as a PET imaging agent in a prostate cancer mouse model
|
Lien, Vegard Torp
|
|
|
136-137 |
C |
p. 74-80
|
artikel
|
| 482 |
Preclinical evaluation of [18F]D3FSP, deuterated AV-45, for imaging of β-amyloid in the brain
|
Zha, Zhihao
|
|
|
136-137 |
C |
p. 97-106
|
artikel
|
| 483 |
Preclinical evaluation of 68Ga-labeled folic acid conjugates for visualization of inflammatory foci
|
Petrosova, Kristina A.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 484 |
Preclinical evaluation of heat-denatured [18F]FDG-labeled red blood cells for detecting splenic tissues with PET in rats
|
Matsusaka, Yohji
|
|
2018
|
136-137 |
C |
p. 26-30
|
artikel
|
| 485 |
Pre-clinical evaluation of immunoPET imaging using agonist CD40 monoclonal antibody in pancreatic tumor-bearing mice
|
Aghevlian, Sadaf
|
|
|
136-137 |
C |
p. 8-17
|
artikel
|
| 486 |
Preclinical evaluation of MC1R targeting theranostic pair [155Tb]Tb-crown-αMSH and [161Tb]Tb-crown-αMSH
|
Wharton, Luke
|
|
|
136-137 |
C |
p.
|
artikel
|
| 487 |
Preclinical evaluation of new α-radionuclide therapy targeting LAT1: 2-[211At]astato-α-methyl-L-phenylalanine in tumor-bearing model
|
Ohshima, Yasuhiro
|
|
|
136-137 |
C |
p. 15-22
|
artikel
|
| 488 |
Preclinical investigation of potential use of thymidine phosphorylase-targeting tracer for diagnosis of nonalcoholic steatohepatitis
|
Higashikawa, Kei
|
|
|
136-137 |
C |
p. 25-32
|
artikel
|
| 489 |
Preclinical investigation of the effect of stress on the binding of [18F]F13640, a 5-HT1A radiopharmaceutical
|
Courault, Pierre
|
|
|
136-137 |
C |
p.
|
artikel
|
| 490 |
Preclinical radiolabeling, in vivo biodistribution and positron emission tomography of a novel pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2
|
Wichmann, Christian Werner
|
|
|
136-137 |
C |
p.
|
artikel
|
| 491 |
Preclinical studies of a PARP targeted, Meitner-Auger emitting, theranostic radiopharmaceutical for metastatic ovarian cancer
|
Hoffman, S.L.V.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 492 |
Preclinical study of an 18F-labeled glutamine derivative for cancer imaging
|
Li, Cong
|
|
|
136-137 |
C |
p. 34-40
|
artikel
|
| 493 |
Preclinical validation of [18F]2FNQ1P as a specific PET radiotracer of 5-HT6 receptors in rat, pig, non-human primate and human brain tissue
|
Emery, Stéphane
|
|
|
136-137 |
C |
p. 57-63
|
artikel
|
| 494 |
Predicting response to sepantronium bromide (YM155), a survivin suppressant, by PET imaging with [11C]YM155
|
Mitsuoka, Keisuke
|
|
|
136-137 |
C |
p. 41-46
|
artikel
|
| 495 |
Preferred use of curie (ci) rather than becquerel (Bq) in nuclear medicine practice
|
Pillai, Maroor Raghavan Ambikalmajan
|
|
2017
|
136-137 |
C |
p. 51-52
2 p.
|
artikel
|
| 496 |
Pre-labelling versus direct labelling of anthrax proteins for imaging of matrix metalloproteinases activity using DOTA-GA
|
Xavier, Mary-Ann Elvina
|
|
2019
|
136-137 |
C |
p. 49-54
|
artikel
|
| 497 |
Preliminary evaluation of a novel 18F-labeled PARP-1 ligand for PET imaging of PARP-1 expression in prostate cancer
|
Zhou, Dong
|
|
2018
|
136-137 |
C |
p. 26-31
|
artikel
|
| 498 |
Preliminary evaluation of 18F-labeled LLP2A-trifluoroborate conjugates as VLA-4 (α4β1 integrin) specific radiotracers for PET imaging of melanoma
|
Roxin, Áron
|
|
2018
|
136-137 |
C |
p. 11-20
|
artikel
|
| 499 |
Preoperative [18F]fluoro-PEG-folate PET/CT in advanced stage epithelial ovarian cancer: A safety and feasibility study
|
Ciggaar, Isabeau A.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 500 |
Preparation and evaluation of APTES-PEG coated iron oxide nanoparticles conjugated to rhenium-188 labeled rituximab
|
Azadbakht, Bakhtiar
|
|
2017
|
136-137 |
C |
p. 26-30
5 p.
|
artikel
|
| 501 |
Preparation and evaluation of 111In-labeled liposomes containing phosphatidylglycerol for detection of macrophages in atherosclerotic plaques
|
Munekane, Masayuki
|
|
|
136-137 |
C |
p.
|
artikel
|
| 502 |
Preparation and evaluation of L- and D-5-[18F]fluorotryptophan as PET imaging probes for indoleamine and tryptophan 2,3-dioxygenases
|
Tang, Tang
|
|
2017
|
136-137 |
C |
p. 10-17
8 p.
|
artikel
|
| 503 |
Preparation and evaluation of rhenium-188-pamidronate as a palliative treatment in bone metastasis
|
Erfani, Mostafa
|
|
2017
|
136-137 |
C |
p. 1-7
|
artikel
|
| 504 |
Preparation and in vivo evaluation of red blood cell membrane coated porous silicon nanoparticles implanted with 155Tb
|
Jakobsson, Ulrika
|
|
|
136-137 |
C |
p. 102-110
|
artikel
|
| 505 |
Preparation and labelling of red blood cells with [68Ga]Ga-oxine for PET/CT imaging of the human spleen
|
Drescher, Robert
|
|
|
136-137 |
C |
p.
|
artikel
|
| 506 |
Preparation of a multi-modal agent for sentinel lymph node mapping using Evans blue and 99mTc-labeled mannosylated human serum albumin conjugate
|
Lee, Ji Youn
|
|
|
136-137 |
C |
p. 38-45
|
artikel
|
| 507 |
Preparation of [177Lu]Lu-DOTA-Ahx-Lys40-Exendin-4 for radiotherapy of insulinoma: a detailed insight into the radiochemical intricacies
|
Guleria, Mohini
|
|
|
136-137 |
C |
p. 31-40
|
artikel
|
| 508 |
Preparation of 212Pb-labeled monoclonal antibody using a novel 224Ra-based generator solution
|
Westrøm, Sara
|
|
2017
|
136-137 |
C |
p. 1-9
9 p.
|
artikel
|
| 509 |
Production and purification of radiolabeling-ready 132/135La from the irradiation of metallic natBa targets with low energy protons
|
Kurakina, E.S.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 510 |
Production and radiochemistry of antimony-120m: Efforts toward Auger electron therapy with 119Sb
|
Kostelnik, Thomas I.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 511 |
Production, isolation, and shipment of clinically relevant quantities of astatine-211: A simple and efficient approach to increasing supply
|
McIntosh, Lauren A.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 512 |
Production of positron-emitting radionuclide yttrium-86 with a computer-aided design target for positron emission tomography
|
Chen, Junyi
|
|
|
136-137 |
C |
p. 54-60
|
artikel
|
| 513 |
Production of Zr-89 using sputtered yttrium coin targets
|
Queern, Stacy Lee
|
|
2017
|
136-137 |
C |
p. 11-16
|
artikel
|
| 514 |
Production, purification and availability of 211At: Near term steps towards global access
|
Feng, Yutian
|
|
|
136-137 |
C |
p. 12-23
|
artikel
|
| 515 |
Production, purification and formulation of nanoradiopharmaceutical with 211At: An emerging candidate for targeted alpha therapy
|
Ghosh, Sanchita
|
|
|
136-137 |
C |
p.
|
artikel
|
| 516 |
Professor Jon Dilworth: Shining a Light on the Chemistry of Metals Used in Biology, Medicine and Radiochemistry
|
Dilworth, Jonathan R.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 517 |
Prostate cancer and inflammation: A new molecular imaging challenge in the era of personalized medicine
|
Schillaci, Orazio
|
|
2019
|
136-137 |
C |
p. 66-79
|
artikel
|
| 518 |
Proton-induced production and radiochemical isolation of 44Ti from scandium metal targets for 44Ti/44Sc generator development
|
Radchenko, Valery
|
|
2017
|
136-137 |
C |
p. 25-32
|
artikel
|
| 519 |
PSMA-reactive NB7 single domain antibody fragment: A potential scaffold for developing prostate cancer theranostics
|
Huynh, Truc T.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 520 |
Publisher’s note
|
|
|
|
136-137 |
C |
p.
|
artikel
|
| 521 |
Quantitation of rat cerebral blood flow using 99mTc-HMPAO
|
Suzuki, Chie
|
|
2017
|
136-137 |
C |
p. 19-22
|
artikel
|
| 522 |
Quantitative imaging using [18F]F-TZ3108 to assess metabolic-associated fatty liver disease progression and low-carbohydrate diet efficacy
|
Han, Zongping
|
|
|
136-137 |
C |
p.
|
artikel
|
| 523 |
Radiation dosimetry and efficacy of an 89Zr/225Ac-labeled humanized anti-MUC5AC antibody
|
Nakata, Norihito
|
|
|
136-137 |
C |
p. 33-43
|
artikel
|
| 524 |
Radiation dosimetry of [18F]GP1 for imaging activated glycoprotein IIb/IIIa receptors with positron emission tomography in patients with acute thromboembolism
|
Lee, Narae
|
|
2019
|
136-137 |
C |
p. 45-48
|
artikel
|
| 525 |
Radiation dosimetry of the 18 kDa translocator protein ligand [18F]PBR111 in humans
|
Tournier, Benjamin B.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 526 |
Radiation induced oxidation of [18F]fluorothia fatty acids under cGMP manufacturing conditions
|
Pandey, Mukesh K.
|
|
|
136-137 |
C |
p. 13-23
|
artikel
|
| 527 |
Radioarsenic: A promising theragnostic candidate for nuclear medicine
|
Sanders, Vanessa A.
|
|
|
136-137 |
C |
p. 184-201
|
artikel
|
| 528 |
Radiobiological effect of alpha particles. The scientific basis of targeted alpha-particle therapy
|
Cruz-Nova, Pedro
|
|
|
136-137 |
C |
p.
|
artikel
|
| 529 |
Radiochemical and biological properties of peptides designed to interact with EGF receptor: Relevance for glioblastoma
|
Sobral, Danielle V.
|
|
|
136-137 |
C |
p. 14-23
|
artikel
|
| 530 |
Radiochemistry of cyclen-derived chelators comprising five-membered azaheterocyclic arms with 212Pb2+, 213Bi3+, and 225Ac3+
|
Hierlmeier, Ina
|
|
|
136-137 |
C |
p.
|
artikel
|
| 531 |
Radioimmunotherapy of human pancreatic cancer xenografts in NOD-scid mice with [64Cu]Cu-NOTA-panitumumab F(ab′)2 alone or combined with radiosensitizing gemcitabine and the PARP inhibitor, rucaparib
|
Boyle, Amanda J.
|
|
|
136-137 |
C |
p. 46-54
|
artikel
|
| 532 |
Radiolabeling and biological characterization of TPGS-based nanomicelles by means of small animal imaging
|
Tesan, Fiorella Carla
|
|
2017
|
136-137 |
C |
p. 62-68
7 p.
|
artikel
|
| 533 |
Radiolabeling of a polypeptide polymer for intratumoral delivery of alpha-particle emitter, 225Ac, and beta-particle emitter, 177Lu
|
Shalgunov, Vladimir
|
|
|
136-137 |
C |
p. 11-21
|
artikel
|
| 534 |
Radiolabeling of PSMA-617 with 89Zr: A novel use of DMSO to improve radiochemical yield and preliminary small-animal PET results
|
Imura, Ryota
|
|
|
136-137 |
C |
p. 21-28
|
artikel
|
| 535 |
Radiolabeling with [11C]HCN for Positron emission tomography
|
Zhou, Yu-Peng
|
|
|
136-137 |
C |
p. 56-86
|
artikel
|
| 536 |
Radiolabeling yield dependency of post-dry distillation decay of astatine-211
|
Hansson, Ellinor
|
|
|
136-137 |
C |
p.
|
artikel
|
| 537 |
Radiolabelling and positron emission tomography imaging of a high-affinity peptide binder to collagen type 1
|
Rosestedt, Maria
|
|
|
136-137 |
C |
p. 54-62
|
artikel
|
| 538 |
Radiolanthanum: Promising theranostic radionuclides for PET, alpha, and Auger-Meitner therapy
|
Nelson, Bryce J.B.
|
|
|
136-137 |
C |
p. 59-66
|
artikel
|
| 539 |
Radiopharmaceutical chemistry of targeted radiotherapeutics, part 4: Strategies for 211At labeling at high activities and radiation doses of 211At α-particles
|
Pozzi, Oscar R.
|
|
2017
|
136-137 |
C |
p. 43-49
7 p.
|
artikel
|
| 540 |
Radiopharmacologic screening of antibodies to the unshed ectodomain of MUC16 in ovarian cancer identifies a lead candidate for clinical translation
|
Nemieboka, Brandon
|
|
|
136-137 |
C |
p. 9-19
|
artikel
|
| 541 |
Radiopharmacy in Africa: current status and future directions
|
Ekoume, F.P.
|
|
|
136-137 |
C |
p. 29-33
|
artikel
|
| 542 |
Radiosynthesis and biological evaluation of N-(2-[18F]fluoropropionyl)-3,4-dihydroxy-l-phenylalanine as a PET tracer for oncologic imaging
|
Tang, Caihua
|
|
2017
|
136-137 |
C |
p. 39-46
|
artikel
|
| 543 |
Radiosynthesis and characterization of a carbon-11 PET tracer for receptor-interacting protein kinase 1
|
Huang, Tianyu
|
|
|
136-137 |
C |
p. 18-27
|
artikel
|
| 544 |
Radiosynthesis and evaluation of 18F-labeled dopamine D4-receptor ligands
|
Willmann, Michael
|
|
|
136-137 |
C |
p. 43-52
|
artikel
|
| 545 |
Radiosynthesis and evaluation of N5-(2-18F-fluoropropanyl) ornithine as a potential agent for tumor PET imaging
|
Wang, Hongliang
|
|
|
136-137 |
C |
p. 98-105
|
artikel
|
| 546 |
Radiosynthesis and initial preclinical evaluation of [11C]AZD1283 as a potential P2Y12R PET radiotracer
|
Jackson, Isaac M.
|
|
|
136-137 |
C |
p. 143-150
|
artikel
|
| 547 |
Radiosynthesis and in vivo evaluation of a new positron emission tomography radiotracer targeting bromodomain and extra-terminal domain (BET) family proteins
|
Bai, Ping
|
|
|
136-137 |
C |
p. 96-101
|
artikel
|
| 548 |
Radiosynthesis, in vitro and preliminary in vivo evaluation of the novel glutamine derived PET tracers [18F]fluorophenylglutamine and [18F]fluorobiphenylglutamine
|
Baguet, Tristan
|
|
|
136-137 |
C |
p. 20-29
|
artikel
|
| 549 |
Rapid and automated production of [68Ga]gallium chloride and [68Ga]Ga-DOTA-TATE on a medical cyclotron
|
Tieu, William
|
|
|
136-137 |
C |
p. 12-18
|
artikel
|
| 550 |
Rapid detection of SARS-CoV-2 using a radiolabeled antibody
|
Pirovano, Giacomo
|
|
|
136-137 |
C |
p. 69-75
|
artikel
|
| 551 |
Rapid, high-yield enzymatic synthesis of n.c.a. 6-[18F]fluorodopamine (6-[18F]FDA) for in vivo application
|
Bamminger, Karsten
|
|
|
136-137 |
C |
p. 189-197
|
artikel
|
| 552 |
Reactive oxygen species-driven HIF1α triggers accelerated glycolysis in endothelial cells exposed to low oxygen tension
|
Paik, Jin-Young
|
|
2017
|
136-137 |
C |
p. 8-14
7 p.
|
artikel
|
| 553 |
Re-assessing gallium-67 as a therapeutic radionuclide
|
Othman, Muhamad F. bin
|
|
2017
|
136-137 |
C |
p. 12-18
7 p.
|
artikel
|
| 554 |
Recent advancements in 18F-labeled PSMA targeting PET radiopharmaceuticals
|
Piron, Sarah
|
|
|
136-137 |
C |
p. 29-51
|
artikel
|
| 555 |
Re(CO)3([18F]FEDA), a novel 18F PET renal tracer: Radiosynthesis and preclinical evaluation
|
Lipowska, Malgorzata
|
|
2018
|
136-137 |
C |
p. 42-50
|
artikel
|
| 556 |
Reconsider logP!
|
Vraka, Chrysoula
|
|
2017
|
136-137 |
C |
p. 42-
1 p.
|
artikel
|
| 557 |
Redesign of negatively charged 111In-DTPA-octreotide derivative to reduce renal radioactivity
|
Oshima, Nobuhiro
|
|
2017
|
136-137 |
C |
p. 16-25
10 p.
|
artikel
|
| 558 |
Reduction of the hepatic radioactivity levels of [111In]In-DOTA–labeled antibodies via cleavage of a linkage metabolized in lysosomes
|
Suzuki, Hiroyuki
|
|
|
136-137 |
C |
p.
|
artikel
|
| 559 |
Reduction of tumor hypoxia by anti-PD-1 therapy assessed using pimonidazole and [18F]FMISO
|
Nakajima, Kohei
|
|
|
136-137 |
C |
p. 85-92
|
artikel
|
| 560 |
Regiospecific radiolabelling of Nanofitin on Ni magnetic beads with [18F]FBEM and in vivo PET studies
|
Dammicco, Sylvestre
|
|
2017
|
136-137 |
C |
p. 33-39
7 p.
|
artikel
|
| 561 |
Relationship between [14C]MeAIB uptake and amino acid transporter family gene expression levels or proliferative activity in a pilot study in human carcinoma cells: Comparison with [3H]methionine uptake
|
Kagawa, Shinya
|
|
2017
|
136-137 |
C |
p. 8-15
|
artikel
|
| 562 |
Relative Biological Effectiveness (RBE) of [64Cu]Cu and [177Lu]Lu-NOTA-panitumumab F (ab')2 radioimmunotherapeutic agents vs. γ-radiation for decreasing the clonogenic survival in vitro of human pancreatic ductal adenocarcinoma (PDAC) cells
|
Boyle, Amanda J.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 563 |
Renal brush border strategy: A developing procedure to reduce renal radioactivity levels of radiolabeled polypeptides
|
Arano, Yasushi
|
|
|
136-137 |
C |
p. 149-155
|
artikel
|
| 564 |
Repeatability of brown adipose tissue activation measured by [18F]FDG PET after beta3-adrenergic stimuli in a mouse model
|
de Paula Faria, Daniele
|
|
|
136-137 |
C |
p.
|
artikel
|
| 565 |
RETRACTED: Radiosynthesis and biological evaluation of fluorine-18 labeled N-acetylgalactosamine derivative [18F]FPGalNAc for PET imaging of asialoglycoprotein receptor-positive tumors
|
Sun, Penghui
|
|
|
136-137 |
C |
p. 1-9
|
artikel
|
| 566 |
Review on 99mTc radiopharmaceuticals with emphasis on new advancements
|
Duatti, Adriano
|
|
|
136-137 |
C |
p. 202-216
|
artikel
|
| 567 |
Review: PET imaging with macro- and middle-sized molecular probes
|
Mukai, Hidefumi
|
|
|
136-137 |
C |
p. 156-170
|
artikel
|
| 568 |
Robust high-yield ~1 TBq production of cyclotron based sodium [99mTc]pertechnetate
|
Andersson, J.D.
|
|
2018
|
136-137 |
C |
p. 63-70
|
artikel
|
| 569 |
Role of [99mTc]Tc-Galacto-RGD2 SPECT/CT in identifying metastatic differentiated thyroid carcinoma after thyroidectomy and radioactive iodine therapy
|
Xu, Qinfeng
|
|
|
136-137 |
C |
p. 34-43
|
artikel
|
| 570 |
Second generation Al18F-labeled D-amino acid peptide for CXCR4 targeted molecular imaging
|
Spahn, Muriel Aline
|
|
|
136-137 |
C |
p.
|
artikel
|
| 571 |
Semi-automated system for concentrating 68Ga-eluate to obtain high molar and volume concentration of 68Ga-Radiopharmaca for preclinical applications
|
de Blois, Erik
|
|
|
136-137 |
C |
p. 16-21
|
artikel
|
| 572 |
Serotonin transporter imaging agent as a probe for β-cells of pancreas
|
Sun, Yuli
|
|
|
136-137 |
C |
p.
|
artikel
|
| 573 |
Sex-differences in [68Ga]Ga-DOTANOC biodistribution
|
Leisser, A.
|
|
|
136-137 |
C |
p. 15-20
|
artikel
|
| 574 |
Simple and rapid radiosynthesis of N-18F-labeled glutamic acid as a hepatocellular carcinoma PET tracer
|
Sun, Aixia
|
|
2017
|
136-137 |
C |
p. 38-43
|
artikel
|
| 575 |
Simvastatin augments revascularization and reperfusion in a murine model of hind limb ischemia – Multimodal imaging assessment
|
Goggi, Julian Luke
|
|
2017
|
136-137 |
C |
p. 25-31
7 p.
|
artikel
|
| 576 |
Site-specific radioiodination of an anti-HER2 single domain antibody fragment with a residualizing prosthetic agent
|
Feng, Yutian
|
|
|
136-137 |
C |
p. 171-183
|
artikel
|
| 577 |
Small-scale production of 67Cu for a preclinical study via the 64Ni(α, p)67Cu channel
|
Ohya, Tomoyuki
|
|
2018
|
136-137 |
C |
p. 56-60
|
artikel
|
| 578 |
Solid phase extraction chromatography-based radiochemical isolation of cyclotron-produced 51Mn from enriched 54Fe targets
|
Barrett, Kendall E.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 579 |
Solid phase radiosynthesis of an olaparib derivative using 4-[18F] fluorobenzoic acid and in vivo evaluation in breast and prostate cancer xenograft models for PARP-1 expression
|
Xu, Jinbin
|
|
|
136-137 |
C |
p. 65-70
|
artikel
|
| 580 |
Somatostatin receptor targeting with hydrophilic [99mTc/186Re]Tc/Re-tricarbonyl NODAGA and NOTA complexes
|
Makris, George
|
|
2019
|
136-137 |
C |
p. 39-46
|
artikel
|
| 581 |
Speed matters to raise molar radioactivity: Fast HPLC shortens the quality control of C-11 PET-tracers
|
Nics, Lukas
|
|
2018
|
136-137 |
C |
p. 28-33
|
artikel
|
| 582 |
Status and future perspectives of Meitner-Auger and low energy electron-emitting radionuclides for targeted radionuclide therapy
|
Radchenko, Valery
|
|
|
136-137 |
C |
p. 106
|
artikel
|
| 583 |
Status of radiobiology in molecular radionuclide therapy – Hope for the future
|
Nonnekens, Julie
|
|
|
136-137 |
C |
p. 45-46
|
artikel
|
| 584 |
Status of the ‘consensus nomenclature rules in radiopharmaceutical sciences’ initiative
|
Coenen, Heinz H.
|
|
2019
|
136-137 |
C |
p. 19-22
|
artikel
|
| 585 |
Structure-affinity-pharmacokinetics relationships of 111In-labeled PSMA-targeted ligands with different albumin binders
|
Yamaguchi, Keisei
|
|
|
136-137 |
C |
p.
|
artikel
|
| 586 |
Study of activation cross sections of double neutron capture reaction on 193Ir for the reactor production route of radiotherapeutic 195mPt
|
Madumarov, Alexander S.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 587 |
Synthesis and characterization of 64Cu-labeled Geldanamycin derivative for imaging HSP90 expression in breast cancer
|
Li, Feng
|
|
|
136-137 |
C |
p.
|
artikel
|
| 588 |
Synthesis and characterization of [125I]TZ6544, a promising radioligand for investigating sphingosine-1-phosphate receptor 2
|
Luo, Zonghua
|
|
|
136-137 |
C |
p. 52-61
|
artikel
|
| 589 |
Synthesis and evaluation of a 68Ga-labeled spermine derivative for tumor PET imaging
|
Qin, Kaixin
|
|
|
136-137 |
C |
p.
|
artikel
|
| 590 |
Synthesis and evaluation of a 99mTc-labeled chemokine receptor antagonist peptide for imaging of chemokine receptor expressing tumors
|
Mikaeili, Azadeh
|
|
2017
|
136-137 |
C |
p. 10-17
8 p.
|
artikel
|
| 591 |
Synthesis and evaluation of a 99mTc-labelled deuterated tropane derivative as a SPECT probe for dopamine transporter
|
Kang, Jing
|
|
|
136-137 |
C |
p.
|
artikel
|
| 592 |
Synthesis and evaluation of a 99mTc tricarbonyl-labeled somatostatin receptor-targeting antagonist peptide for imaging of neuroendocrine tumors
|
Radford, Lauren
|
|
2017
|
136-137 |
C |
p. 4-9
|
artikel
|
| 593 |
Synthesis and evaluation of a multifunctional probe with a high affinity for prostate-specific membrane antigen (PSMA) and bone
|
Hirata, Saki
|
|
|
136-137 |
C |
p. 34-41
|
artikel
|
| 594 |
Synthesis and evaluation of an N-[18F]fluorodeoxyglycosyl amino acid for PET imaging of tumor metabolism
|
Wu, Zhifang
|
|
2018
|
136-137 |
C |
p. 40-48
|
artikel
|
| 595 |
Synthesis and evaluation of a novel urea-based 68Ga-complex for imaging PSMA binding in tumor
|
Zha, Zhihao
|
|
2018
|
136-137 |
C |
p. 36-47
|
artikel
|
| 596 |
Synthesis and evaluation of a para-carboxylated benzyl-DOTA for labeling peptides and polypeptides
|
Suzuki, Hiroyuki
|
|
|
136-137 |
C |
p. 18-28
|
artikel
|
| 597 |
Synthesis and evaluation of [18F]cinacalcet for the imaging of parathyroid hyperplasia
|
Pees, Anna
|
|
|
136-137 |
C |
p. 97-105
|
artikel
|
| 598 |
Synthesis and evaluation of 6-[18F]fluoro-3-(pyridin-3-yl)-1H-indole as potential PET tracer for targeting tryptophane 2, 3-dioxygenase (TDO)
|
Qiao, Zheng
|
|
|
136-137 |
C |
p. 1-10
|
artikel
|
| 599 |
Synthesis and evaluation of [18F]FP-Lys-GE11 as a new radiolabeled peptide probe for epidermal growth factor receptor (EGFR) imaging
|
Li, Xueli
|
|
|
136-137 |
C |
p. 84-92
|
artikel
|
| 600 |
Synthesis and evaluation of 68Ga-labeled imidazothiadiazole sulfonamide derivatives for PET imaging of carbonic anhydrase-IX
|
Nakashima, Kazuma
|
|
|
136-137 |
C |
p. 46-53
|
artikel
|
| 601 |
Synthesis and evaluation of 99mTc-analogues of [123/131I]mIBG prepared via [99mTc][Tc(CO)3(H2O)3]+ synthon for targeting norepinephrine transporter
|
Das, Soumen
|
|
2019
|
136-137 |
C |
p. 49-57
|
artikel
|
| 602 |
Synthesis and evaluation of 99mTc/Re-tricarbonyl complexes of the triphenylphosphonium cation for mitochondrial targeting
|
Paparidis, Georgios
|
|
2018
|
136-137 |
C |
p. 34-41
|
artikel
|
| 603 |
Synthesis and evaluation of novel trifunctional chelating agents for pretargeting approach using albumin binder to improve tumor accumulation
|
Tsuchihashi, Shohei
|
|
|
136-137 |
C |
p.
|
artikel
|
| 604 |
Synthesis and evaluation of 2-pyrrolopyridinylquinoline derivatives as selective tau PET tracers for the diagnosis of Alzheimer's disease
|
Lerdsirisuk, Pradith
|
|
|
136-137 |
C |
p. 11-18
|
artikel
|
| 605 |
Synthesis and evaluation of two new candidate high-affinity full agonist PET radioligands for imaging 5-HT1B receptors
|
Lindberg, Anton
|
|
2019
|
136-137 |
C |
p. 1-13
|
artikel
|
| 606 |
Synthesis and evaluation of zirconium-89 labelled and long-lived GLP-1 receptor agonists for PET imaging
|
Jacobsen, Christian Borch
|
|
|
136-137 |
C |
p. 49-56
|
artikel
|
| 607 |
Synthesis and ex vivo biodistribution of two 68Ga-labeled tetrazine tracers: Comparison of pharmacokinetics
|
Lambidis, Elisavet
|
|
|
136-137 |
C |
p. 151-161
|
artikel
|
| 608 |
Synthesis and fluorine-18 radiolabeling of a phospholipid as a PET imaging agent for prostate cancer
|
Kwan, Kim H.
|
|
|
136-137 |
C |
p. 37-45
|
artikel
|
| 609 |
Synthesis and preclinical evaluation of [11C]LR111 and [18F]EW-7197 as PET tracers of the activin-receptor like kinase-5
|
Rotteveel, Lonneke
|
|
|
136-137 |
C |
p. 9-19
|
artikel
|
| 610 |
Synthesis and preclinical evaluation of [18F]AlF-NODA-MP-C6-CTHRSSVVC as a PET tracer for CD163-positive tumor-infiltrating macrophages
|
Fernandes, Bruna
|
|
|
136-137 |
C |
p.
|
artikel
|
| 611 |
Synthesis and preclinical evaluation of the CRTH2 antagonist [11C]MK-7246 as a novel PET tracer and potential surrogate marker for pancreatic beta-cell mass
|
Eriksson, Jonas
|
|
2019
|
136-137 |
C |
p. 1-10
|
artikel
|
| 612 |
Synthesis and preclinical evaluation of two osimertinib isotopologues labeled with carbon-11 as PET tracers targeting the tyrosine kinase domain of the epidermal growth factor receptor
|
Högnäsbacka, Antonia
|
|
|
136-137 |
C |
p.
|
artikel
|
| 613 |
Synthesis and preliminary evaluation of 211At-labeled inhibitors of prostate-specific membrane antigen for targeted alpha particle therapy of prostate cancer
|
Vaidyanathan, Ganesan
|
|
|
136-137 |
C |
p. 67-80
|
artikel
|
| 614 |
Synthesis, characterization and biological studies of rhenium, technetium-99m and rhenium-188 pentapeptides
|
Sanders, Vanessa A.
|
|
2019
|
136-137 |
C |
p. 1-13
|
artikel
|
| 615 |
Synthesis, in vitro and in vivo evaluation of 18F-fluoronorimatinib as radiotracer for Imatinib-sensitive gastrointestinal stromal tumors
|
Prause, Martin
|
|
2018
|
136-137 |
C |
p. 1-11
|
artikel
|
| 616 |
Synthesis of 11C-labeled DNA polymerase-β inhibitor 5-methoxyflavone and PET/CT imaging thereof
|
Chen, Zude
|
|
|
136-137 |
C |
p. 17-22
|
artikel
|
| 617 |
Synthesis of [18F] fluorine-labeled K-2 derivatives as radiotracers for AMPA receptors
|
Arisawa, Tetsu
|
|
|
136-137 |
C |
p. 47-58
|
artikel
|
| 618 |
Synthesis of N-(6-[18F]Fluoropyridin-3-yl)glycine as a potential renal PET agent
|
Wang, Hongliang
|
|
|
136-137 |
C |
p. 21-27
|
artikel
|
| 619 |
Synthesis, radiolabeling and preclinical evaluation of a [11C]GMOM derivative as PET radiotracer for the ion channel of the N-methyl-D-aspartate receptor
|
Klein, Pieter J.
|
|
2017
|
136-137 |
C |
p. 25-32
8 p.
|
artikel
|
| 620 |
Synthesis, radiolabeling, and preclinical in vivo evaluation of 68Ga-radiolabelled nanodiamonds
|
Wanek, Thomas
|
|
|
136-137 |
C |
p.
|
artikel
|
| 621 |
Table of Contents
|
|
|
2017
|
136-137 |
C |
p. IBC-
1 p.
|
artikel
|
| 622 |
Table of Contents
|
|
|
2017
|
136-137 |
C |
p. IBC-
1 p.
|
artikel
|
| 623 |
Table of Contents
|
|
|
2017
|
136-137 |
C |
p. IBC-
1 p.
|
artikel
|
| 624 |
Table of Contents
|
|
|
2017
|
136-137 |
C |
p. IBC-
1 p.
|
artikel
|
| 625 |
Table of Contents
|
|
|
2017
|
136-137 |
C |
p. IBC-
1 p.
|
artikel
|
| 626 |
Table of Contents
|
|
|
2017
|
136-137 |
C |
p. IBC-
1 p.
|
artikel
|
| 627 |
Table of Contents
|
|
|
2018
|
136-137 |
C |
p. IBC
|
artikel
|
| 628 |
Table of Contents
|
|
|
|
136-137 |
C |
p. IBC
|
artikel
|
| 629 |
Table of Contents
|
|
|
|
136-137 |
C |
p. IBC
|
artikel
|
| 630 |
Table of Contents
|
|
|
2018
|
136-137 |
C |
p. IBC
|
artikel
|
| 631 |
Table of Contents
|
|
|
2017
|
136-137 |
C |
p. IBC
|
artikel
|
| 632 |
Table of Contents
|
|
|
2018
|
136-137 |
C |
p. IBC
|
artikel
|
| 633 |
Table of Contents
|
|
|
2017
|
136-137 |
C |
p. IBC-
1 p.
|
artikel
|
| 634 |
Table of Contents
|
|
|
2017
|
136-137 |
C |
p. IBC-
1 p.
|
artikel
|
| 635 |
Table of Contents
|
|
|
2017
|
136-137 |
C |
p. IBC
|
artikel
|
| 636 |
Table of Contents
|
|
|
2017
|
136-137 |
C |
p. IBC
|
artikel
|
| 637 |
Table of Contents
|
|
|
2017
|
136-137 |
C |
p. IBC
|
artikel
|
| 638 |
Table Of Contents
|
|
|
2018
|
136-137 |
C |
p. IBC
|
artikel
|
| 639 |
Table of Contents
|
|
|
2018
|
136-137 |
C |
p. IBC
|
artikel
|
| 640 |
Table of Contents
|
|
|
2018
|
136-137 |
C |
p. IBC
|
artikel
|
| 641 |
Table of Contents & Barcode
|
|
|
2018
|
136-137 |
C |
p. IBC
|
artikel
|
| 642 |
Table of Contents & Barcode
|
|
|
2018
|
136-137 |
C |
p. IBC
|
artikel
|
| 643 |
Tactics for preclinical validation of receptor-binding radiotracers
|
Lever, Susan Z.
|
|
2017
|
136-137 |
C |
p. 4-30
27 p.
|
artikel
|
| 644 |
Taking cyclotron 68Ga production to the next level: Expeditious solid target production of 68Ga for preparation of radiotracers
|
Nelson, Bryce J.B.
|
|
|
136-137 |
C |
p. 24-31
|
artikel
|
| 645 |
Targeted Auger electron-emitter therapy: Radiochemical approaches for thallium-201 radiopharmaceuticals
|
Rigby, Alex
|
|
|
136-137 |
C |
p. 1-7
|
artikel
|
| 646 |
Target engagement of an anti-MT1-MMP antibody for triple-negative breast cancer PET imaging and beta therapy
|
Magro, Natalia
|
|
|
136-137 |
C |
p.
|
artikel
|
| 647 |
Targeting phosphatidylethanolamine and phosphatidylserine for imaging apoptosis in cancer
|
Li, Junling
|
|
|
136-137 |
C |
p. 23-30
|
artikel
|
| 648 |
Target manufacturing by Spark Plasma Sintering for efficient 89Zr production
|
Cisternino, S.
|
|
|
136-137 |
C |
p. 38-46
|
artikel
|
| 649 |
Terbium-161 in nuclear medicine: Preclinical and clinical progress in comparison with lutetium-177
|
Trejtnar, František
|
|
|
136-137 |
C |
p.
|
artikel
|
| 650 |
The development of 11C-carbonylation chemistry: A systematic view
|
Eriksson, Jonas
|
|
|
136-137 |
C |
p. 115-137
|
artikel
|
| 651 |
The effect of hypoxia on the induction of strand breaks in plasmid DNA by alpha-, beta- and Auger electron-emitters 223Ra, 188Re, 99mTc and DNA-binding 99mTc-labeled pyrene
|
Reissig, Falco
|
|
|
136-137 |
C |
p. 65-70
|
artikel
|
| 652 |
The emerging role of artificial intelligence and digital twins in pre-clinical molecular imaging
|
Currie, Geoffrey M.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 653 |
The emerging role of cell surface receptor and protein binding radiopharmaceuticals in cancer diagnostics and therapy
|
Aloj, Luigi
|
|
|
136-137 |
C |
p. 53-64
|
artikel
|
| 654 |
The future of the radiopharmaceutical sciences
|
Lapi, Suzanne E.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 655 |
The impact of age on radium-223 distribution and an evaluation of molecular imaging surrogates
|
Jiang, Wen
|
|
|
136-137 |
C |
p. 1-8
|
artikel
|
| 656 |
The impact of barium isotopes in radiopharmacy and nuclear medicine – From past to presence
|
Reissig, Falco
|
|
|
136-137 |
C |
p. 59-68
|
artikel
|
| 657 |
The importance of radiochemical purity: Cellular binding and internalization of different radiometal chlorides in prostate cancer cells
|
Raitanen, Julia
|
|
|
136-137 |
C |
p.
|
artikel
|
| 658 |
The past, present, and the promise of the future of nuclear medicine and biology
|
Eckelman, W.C.
|
|
2017
|
136-137 |
C |
p. 47-48
|
artikel
|
| 659 |
The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[18F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historical review
|
Katzenellenbogen, John A.
|
|
|
136-137 |
C |
p. 24-37
|
artikel
|
| 660 |
Theranostic cobalt-55/58m for neurotensin receptor-mediated radiotherapy in vivo: A pilot study with dosimetry
|
Lin, Wilson
|
|
|
136-137 |
C |
p.
|
artikel
|
| 661 |
Theranostic nanoparticles: Investigation of superparamagnetic iron oxide nanoparticles intrinsically labeled with Zirconium-89 and Actinium-225
|
Diehl, George
|
|
|
136-137 |
C |
p.
|
artikel
|
| 662 |
The salivary glands as a dose limiting organ of PSMA- targeted radionuclide therapy: A review of the lessons learnt so far
|
Heynickx, Nathalie
|
|
|
136-137 |
C |
p. 30-39
|
artikel
|
| 663 |
Time-dependent transcriptional response of GOT1 human small intestine neuroendocrine tumor after 177Lu[Lu]-octreotate therapy
|
Spetz, Johan
|
|
2018
|
136-137 |
C |
p. 11-18
|
artikel
|
| 664 |
45Ti targeted tracers for PET imaging of PSMA
|
Chaple, Ivis F.
|
|
|
136-137 |
C |
p. 16-23
|
artikel
|
| 665 |
Towards imaging the immune state of cancer by PET: Targeting legumain with 11C-labeled P1-Asn peptidomimetics carrying a cyano-warhead
|
Lustenberger, Severin K.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 666 |
Towards the development of a targeted albumin-binding radioligand: Synthesis, radiolabelling and preliminary in vivo studies
|
Driver, Cathryn Helena Stanford
|
|
|
136-137 |
C |
p. 53-66
|
artikel
|
| 667 |
Tracer development for PET imaging of proteinopathies
|
Kallinen, Annukka
|
|
|
136-137 |
C |
p. 115-127
|
artikel
|
| 668 |
Tracking the fate of bacteria-derived site-specific immunomodulators by positron emission tomography
|
Kirby, Alexia
|
|
|
136-137 |
C |
p.
|
artikel
|
| 669 |
Training the next generation of radiopharmaceutical scientists
|
Gee, Antony D.
|
|
|
136-137 |
C |
p. 10-13
|
artikel
|
| 670 |
Transcatheter pseudo-vascular isolation for localization and concentration of a large molecule theranostic probe into a transgenic OncoPIG kidney tumor
|
Rice, Samuel L.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 671 |
Transmembrane protein 106B amyloid is a potential off-target molecule of tau PET tracers in the choroid plexus
|
Yokoyama, Yuka
|
|
|
136-137 |
C |
p.
|
artikel
|
| 672 |
Transport mechanism and affinity of [99mTc]Tc-mercaptoacetyltriglycine ([99mTc]MAG3) on the apical membrane of renal proximal tubule cells
|
Kobayashi, Masato
|
|
|
136-137 |
C |
p. 33-37
|
artikel
|
| 673 |
Trithiol ligand provides tumor-targeting 191Pt-complexes with high molar activity and promising in vivo properties
|
Obata, Honoka
|
|
|
136-137 |
C |
p.
|
artikel
|
| 674 |
Tumor uptake and tumor/blood ratios for [89Zr]Zr-DFO-trastuzumab-DM1 on microPET/CT images in NOD/SCID mice with human breast cancer xenografts are directly correlated with HER2 expression and response to trastuzumab-DM1
|
Al-saden, Noor
|
|
2018
|
136-137 |
C |
p. 43-51
|
artikel
|
| 675 |
Ubiquicidin derived peptides for infection imaging
|
Sachdeva, Anoushka
|
|
|
136-137 |
C |
p.
|
artikel
|
| 676 |
Unexpected decrease in in vivo binding of [3H]QNB in the mouse cerebral cortex in the developing brain - A comparison with [11C]NMPB
|
Inoue, Osamu
|
|
2018
|
136-137 |
C |
p. 15-20
|
artikel
|
| 677 |
Uptake of nicotinic acetylcholine receptor imaging agent is reduced in the pro-inflammatory macrophage
|
Suzuki, Motofumi
|
|
|
136-137 |
C |
p. 45-55
|
artikel
|
| 678 |
Use of radiolabeled hyaluronic acid for preclinical assessment of inflammatory injury and acute respiratory distress syndrome
|
Zhao, Fangyuan
|
|
|
136-137 |
C |
p. 86-98
|
artikel
|
| 679 |
Validation of hepatobiliary transport PET imaging in liver function assessment: Evaluation of 3β-[18F]FCA in mouse models of liver disease
|
De Lombaerde, Stef
|
|
2019
|
136-137 |
C |
p. 40-48
|
artikel
|
| 680 |
Validation of the plasmid study to relate DNA damaging effects of radionuclides to those from external beam radiotherapy
|
Verger, Elise
|
|
|
136-137 |
C |
p. 36-43
|
artikel
|
| 681 |
Visualization of a novel human monoclonal antibody against Claudin-3 for targeting ovarian cancer
|
Oh, Sera
|
|
|
136-137 |
C |
p. 135-142
|
artikel
|
| 682 |
Visualization research on ENT1/NIS dual-function gene therapy to reverse drug resistance mediated by MUC1 in GEM-resistant pancreatic cancer
|
Xi, Yun
|
|
|
136-137 |
C |
p.
|
artikel
|
| 683 |
VMAT2 imaging agent, D6-[18F]FP-(+)-DTBZ: Improved radiosynthesis, purification by solid-phase extraction and characterization
|
Zhao, Ruiyue
|
|
2019
|
136-137 |
C |
p. 26-35
|
artikel
|
| 684 |
VPAC1 Targeted 64Cu-TP3805 kit preparation and its evaluation
|
Tripathi, Sushil K.
|
|
2017
|
136-137 |
C |
p. 55-61
7 p.
|
artikel
|
| 685 |
What about α
v
β
3 integrins in molecular imaging in oncology?
|
Debordeaux, Frederic
|
|
|
136-137 |
C |
p. 31-46
|
artikel
|
| 686 |
Whole-body biodistribution of the cannabinoid type 1 receptor ligand [18F]MK-9470 in the rat
|
Buchholz, H.G.
|
|
2017
|
136-137 |
C |
p. 63-69
7 p.
|
artikel
|
| 687 |
William C. Eckelman: An anchor of stability with a quiet voice that nurtured a new field
|
Katzenellenbogen, John A.
|
|
|
136-137 |
C |
p. 2-4
|
artikel
|
| 688 |
William C. Eckelman, an icon of radiopharmaceutical sciences
|
Windhorst, A.D.
|
|
|
136-137 |
C |
p. 1
|
artikel
|
| 689 |
Women in radiopharmaceutical/radiochemical sciences
|
Choe, Yearn Seong
|
|
|
136-137 |
C |
p. 108-114
|
artikel
|
| 690 |
90Y radioembolization dosimetry using a simple semi-quantitative method in intrahepatic cholangiocarcinoma: Glass versus resin microspheres
|
Nezami, Nariman
|
|
2018
|
136-137 |
C |
p. 22-28
|
artikel
|
| 691 |
89Zr for antibody labeling and in vivo studies – A comparison between liquid and solid target production
|
Dias, Gemma M.
|
|
2018
|
136-137 |
C |
p. 1-7
|
artikel
|
| 692 |
[89Zr]ZrCl4 for direct radiolabeling of DOTA-based precursors
|
Lyashchenko, Serge K.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 693 |
[89Zr]Zr-DBN labeled cardiopoietic stem cells proficient for heart failure
|
Bansal, Aditya
|
|
|
136-137 |
C |
p. 23-30
|
artikel
|
Tijdschrift beschrijving